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ABSTRACT

Dhillon, Jaapna. Ph.D., Purdue University, August 2016. The Effects of Including
Almonds in an Energy-restricted Diet on Weight, Body Composition, Visceral Adipose
Tissue, Blood pressure and Cognitive Function. Major Professor: Richard Mattes.

Inclusion of almonds in an energy restricted diet has been reported to enhance or
have no effect on weight loss. Their effects specifically on visceral fat stores during
energy restriction have not been widely examined. Additionally, almond consumption has
been associated with reduced blood pressure, but whether this is linked to or is
independent of changes of body composition has not been examined. Moreover, almond
consumption during energy restriction may be an effective strategy for reversing the
negative effects of dieting on cognitive performance. The unique nutrient profile of
almonds also has the potential to influence cognitive function post-prandially. The postlunch dip in cognition is a well-established phenomenon of decreased alertness, memory
and vigilance after lunch consumption and can be affected by lunch composition.
Almonds which are higher in fat and lower in carbohydrate may be able to reduce this
post lunch dip in cognition. Consequently, this dissertation had three primary aims. The
first aim was to evaluate the effects of almond consumption as part of an energyrestricted diet on weight, visceral and subcutaneous adipose depots and blood pressure
compared to a nut-free energy restricted diet. The second aim was to evaluate the effects

xiii
of almond consumption as part of an energy-restricted diet on cognitive function. The
third aim was to evaluate the acute effects of almond consumption on the post-lunch dip
in cognitive function. A secondary objective of this dissertation was to develop an
analytical approach to identify metabolic profiles associated with almond consumption to
ascertain compliance in long term clinical trials.
Overweight and obese adults (n=86, age: 31.4±12.9 yr, body mass index:
30.4±3.9 kg/m2) were randomly assigned to a 12 week energy restricted (500 kcal/d
deficit) almond-enriched diet (AED) (n=43) or a comparably energy restricted nut-free
diet (NFD) (n=43). Participants in the AED group were asked to consume dry-roasted,
lightly salted almonds providing 15% of energy in individualized energy-restricted diets.
Participants in the NFD group were asked to avoid all nuts during the intervention period.
The same participants were also randomized to receive either a high fat lunch (A-HFL)
(>55% energy from fat, almonds contributing 70-75% lunch energy) or a high
carbohydrate lunch (HCL) (>85% energy from carbohydrates) at the beginning and end
of the intervention.
To isolate biomarkers and metabolite changes related to almond consumption,
representative samples (pools) of erythrocytes from individuals consuming almonds for
12 weeks (n=31) or no almonds (n=30) as well as unmasticated almond seeds were
screened by an untargeted and unbiased metabolomics approach, namely flow injection
mass spectrometry (FIA-MS). Data on full scan mode, specific neutral loss and precursor
ion scan modes for shotgun lipidomics, and m/z values compatible with nut flavonoids
from literature were used. The informative m/z values detected in pooled samples were
combined into single ion monitoring (SIM) and multiple reaction monitoring (MRM)
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methods intended for individual sample screening. This shotgun metabolomics study
identified specific ratios and combinations of membrane lipids that were discriminatory
of almond consumption from the nut-free diet at the end of the 12 week intervention.
Eight out of the 31 participants (25.8%) in the almond group and 3 out of the 30 (10%)
participants in the control group were misclassified indicating a possibility of noncompliance which was supported by self-reported dietary intake data. All subsequent
analyses of the primary study outcomes were based on an intention-to treat approach and
a compliers analysis i.e. analysis of participants compliant to the energy-restriction as
well as their respective intervention groups as determined by the metabolomics study and
self-reported dietary intake data.
The findings from this dissertation research demonstrate that consumption of
almonds during a weight loss regimen resulted in greater proportional reductions of trunk
and total body fat as well as diastolic blood pressure compared to the nut-free weight loss
regimen. Both intervention groups lost similar amounts of weight and visceral adipose
tissue and had similar reductions in systolic blood pressure over time. Hence, almond
consumption during energy restriction may help to reduce metabolic disease risk in
overweight and obese individuals. In addition, both intervention groups demonstrated
similar improvements in memory and attention indices of cognitive function over time.
Moreover, consumption of a midday meal caused a post-lunch dip leading to a decline in
cognitive function. The almond-enriched high-fat lunch reduced the post-lunch dip in
memory but did not affect the dip in attention.
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CHAPTER 1. INTRODUCTION

1.1

Study Rationale

With obesity recently being recognized as a disease(1) there is a concerted effort
towards finding nutrition therapies that can treat obesity and its related health disorders.
Data from epidemiological and clinical studies suggest that consumption of nuts such as
almonds may be an effective strategy for lowering the incidence of obesity and
cardiovascular disease(2,3). Despite their high energy content, the inclusion of almonds in
an energy-restricted diet does not hinder and may augment weight loss(4,5). This may
occur by several mechanisms, but probably most importantly, improved dietary
compliance which is likely attributable to greater sensory variety resulting in higher
palatability of the diet(6); stronger locus of control(8) leading to a sense of empowerment;
and possibly, through their slow and sustained energy release thus ameliorating
physiological process that promote hunger and feeding. The satiating effects of almonds
may prolong inter-meal intervals, promote smaller meal sizes and reduce the desire to eat
when not hungry and, hence, contribute to purposeful weight loss(7). Additionally,
according to the U.S. Food and Drug Administration, consumption of 42.5g nuts, such as
almonds, in conjunction with a diet low in saturated fat and cholesterol, could diminish
cardiovascular disease risk(9). Almonds contain a range of nutrients such as unsaturated
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fats, vitamins, minerals, arginine, polyphenols, fiber etc. that could benefit cardiovascular
health. The primary goal of weight loss is to maximize the reduction of fat mass while
retaining fat-free mass. Dietary factors can be equally or even more effective than
exercise in achieving this outcome. Increasing the proportion of protein in an energyrestricted diet enhances satiety, energy expenditure and greater relative fat mass loss(10).
In addition, different types of dietary fat may influence substrate oxidation.
Monounsaturated fats are oxidized preferentially(11,12), and a diet higher in the
unsaturated:saturated fat ratio may reduce subcutaneous adipose tissue (SAT)(13), but
more importantly, visceral adipose tissue (VAT) during weight loss(14). The promotion of
VAT loss is important clinically as this may translate into the greatest reduction in the
risk for metabolic diseases. Almonds are a good source of protein and monounsaturated
fats and their effects on visceral fat loss, in conjunction with energy restriction, have not
been widely examined.
Additionally, food-derived peptides reduce the risk of cardiovascular disease(15).
Arginine is among these peptides that help to reduce blood pressure. It is the
physiological precursor of nitric oxide which is a vasodilator(16). Certain nuts and seeds
are good plant-based sources of arginine and studies with peanuts (2.8g arginine per 100g
peanuts, as indicated in the USDA National Nutrient Database) reveals their ingestion for
12-weeks leads to a significant reduction in diastolic blood pressure(17). Almonds also
contain high levels of arginine (2.4g arginine per 100g almonds, as indicated in the
USDA National Nutrient Database) and an augmentation of reduction in blood-pressure
could be achieved with almond consumption during weight loss.

3
The process of dieting to lose weight is associated with cognitive function
impairments(18). Impairments of cognition may be a result of food restriction or anxiety
related to maintaining a weight loss regimen. Negative effects of dieting on cognitive
performance have been reversed with nut-supplemented diets higher in fat and lower in
carbohydrate (LCHF)(19). Hence, learning and memory could be enhanced with the
inclusion of almonds during weight loss. In addition, a decrease of memory and vigilance
is often reported after lunch, independent of weight loss(20). This post-lunch dip in
cognitive performance is a well-established phenomenon. It typically occurs in the early
afternoon hours after lunch consumption and may partly be exacerbated by high
carbohydrate meals(21). There is very limited evidence on the effects of nut consumption
on the post-lunch dip in cognitive function. However, the unique nutrient profile of
almonds, which are lower in carbohydrate and higher in protein and unsaturated fats, may
lessen the post-lunch dip.
Assessing compliance to dietary interventions in long-term clinical trials is
problematic. Although self-reported measures of intake such as 24-hour food recalls and
food frequency questionnaires are widely used, these are subjective measures of dietary
intake(22) and only capture a

     



  

Currently, there are

no established analytical methods to ascertain compliance to long-term almond
consumption. Hence, there is a need to develop analytical approaches that can identify
metabolic profiles associated with almond consumption that are discriminatory of
individuals consuming almonds and those that do not in long-term clinical trials.
Nutritional metabolomics is one such tool that can capture the phenotype of dietary
exposure in biological samples(23) such as erythrocytes and can be used for this purpose.
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1.2

Study Objectives

The main objectives of this dissertation are to:
Review the literature on effects of nut consumption on body weight, body
composition, blood pressure and cognitive function, as well as literature
pertaining to the post-lunch dip in cognitive function.
Determine the effects of almond consumption during energy restriction on weight,
body composition, visceral adipose tissue and blood pressure in overweight and
obese adults.
Determine the effects of almonds on cognitive function and the post lunch dip in
energy-restricted overweight and obese adults.
Develop a method for the assessment of compliance to long-term almond
consumption using a shotgun metabolomics approach.

1.3

Organization of dissertation

This dissertation is organized into chapters that contain published manuscripts or
manuscripts submitted to peer-reviewed journals. The details of the publications are
provided at the beginning of the chapters.
Chapter 2 reviews the effects of nut consumption on appetite, dietary
compensation, energy expenditure, fat oxidation and body weight. The focus in this
chapter is on how nut consumption can aid weight management due to their strong
satiating effects, the inefficient absorption of their energy, and possibly by elevating
energy expenditure and fat oxidation.
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Chapter 3 reviews literature on the effects of nut consumption on body
composition, blood pressure, glycemic control, other cardiovascular disease risk factors
and cognitive function including the post-lunch dip in cognitive function. This chapter
establishes the foundation for the outcomes of the almond weight loss clinical trial that
will be discussed in subsequent chapters.
Chapter 4 investigates changes in weight, body composition, specifically visceral
fat and resting blood pressure with almond consumption during 12 weeks of energy
restriction. Changes in secondary outcomes such as anthropometric measures of visceral
adiposity such as waist circumference and sagittal abdominal diameter, 24-hour
ambulatory blood pressure, 24-hour free living appetite ratings, and blood glycemic and
lipid profiles were also assessed.
Chapter 5 investigates the acute effects of almond consumption on the post-lunch
dip in cognitive function as well as changes in cognitive function with almond
consumption during 12 weeks of energy-restriction. The focus in this chapter is on the
memory and attention domains of cognitive function.
Chapter 6 describes the development of a shotgun metabolomics method to
determine compliance to almond consumption in a weight-loss regimen. The focus was
on 1) screening for prospective biomarkers that were discriminatory of almond
consumption from the nut-free diet 2) conducting a performance analysis of specific
combinations and ratios of prospective biomarkers, 3) determining non-compliance to the
almond and nut-free diets via group misclassifications observed in the ratio performance
analysis and 4) confirming possible non-compliance by cross-checking dietary intake
data.
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Chapter 7 summarizes the main dissertation findings and presents future
directions for research.

1.4

Study aims and hypotheses

Specific aim 1: To evaluate the effects of almond consumption as part of an energyrestricted diet on weight, body composition, visceral adipose tissue and blood pressure
compared to a nut-free diet matched on energy restriction (control).
Hypothesis 1: Inclusion of almonds in an energy-restricted diet will augment the rate of
weight loss, lead to greater fat mass loss especially in the visceral depot and reduce blood
pressure compared to the control.
Specific aim 2: To evaluate the effects of almond consumption as part of an energyrestricted diet on cognitive function compared to a nut-free diet matched on energy
restriction (control).
Hypothesis 2: Inclusion of almonds in an energy-restricted diet will improve the attention
and memory domains of cognitive function compared to the control.
Specific aim 3: To determine the post-prandial changes in cognitive function with almond
consumption at lunch compared to a high-carbohydrate control lunch.
Hypothesis 3: Inclusion of almonds in a midday meal will ameliorate the post-lunch
decline in memory and attention compared to a high carbohydrate control meal by
lowering the percentage of dietary energy from carbohydrates and increasing the
percentage of energy from fat.
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CHAPTER 2. A REVIEW OF THE EFFECTS OF NUTS ON APPETITE, FOOD
INTAKE, METABOLISM, AND BODY WEIGHT

Tan S.Y., Dhillon, J. and Mattes R.D. (2014) A review of the effects of nuts on appetite,
food intake, metabolism, and body weight. Am J Clin Nutr 100 (Supplement_1), 412S422S.
An author of an ASN article retains the right to include his/her article in his/her
dissertation.

2.1

Abstract

Tree nuts and peanuts are good sources of many nutrients and antioxidants, but
they are also energy dense. The latter often limits intake because of concerns about their
possible contribution to positive energy balance. However, evidence to date suggests that
nuts are not associated with predicted weight gain. This is largely due to their high satiety
value, leading to strong compensatory dietary responses, inefficiency in absorption of the
energy they contain, a possible increment in resting energy expenditure, and an
augmentation of fat oxidation. Preliminary evidence suggests that these properties are
especially evident when they are consumed as snacks.
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2.2

Introduction

The long-standing pillars of nutrition advice to optimize health are to practice
balance, moderation, and variety. If followed, no food must be excluded from the diet and
each food can make some useful contribution, the value of which is determined by the
health status and needs of the individual. In an era in which positive energy balance has
dominated health concerns in Western nations and is a growing problem globally, highfat, energy-dense foods have often been identified as especially problematic. Nuts are an
example, and one in which the science does not support this perspective. This review
focuses on the role of nut consumption on appetite, energy intake, energy metabolism,
and body weight. Recent studies that report the effects of nuts on various aspects of
human energy balance are summarized in Table 2-1.

2.3

Nuts in the context of the whole diet

Nuts contribute to energy and nutrient intake directly and indirectly via multiple
mechanisms. First, nuts themselves are rich sources of energy, various nutrients (eg,
tocopherols, magnesium, potassium), and antioxidants (1, 2). Each form of nut has its
own inherent sensory profile that is more or less appealing to individual consumers and
so will influence their ingestive decisions. However, the sensory profile of the raw nut is
commonly modified through processing. Roasting and frying darken the color, increase
brittleness, and develop new flavor compounds (3 5). Changes in physical properties are
of particular importance for the acceptability of nuts (6). A wide array of flavor
compounds (eg, salt, sugar, cinnamon, and capsaicin) is also added directly to the surface
of nuts to enhance their appeal. Broadly, such modifications increase sensory variety and,
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by ameliorating monotony effects (7), may facilitate regular nut consumption and intake
of the nutrients they contain. Sensory properties are among the strongest determinants of
ingestive decisions (8, 9).
There are also indirect effects of nut consumption on total energy and nutrient
intake. The sensory, nutrient, and/or physical properties of nuts alter gut hormone
secretion (10, 11) and appetitive responses by consumers (12). In addition, nuts are
frequently incorporated into the matrix of other foods (eg, confections, baked goods, ice
cream), changing the flavor profile of both and creating a unique new unified sensory
stimulus (13) that may guide intake of that item or influence the acceptability and
selection of other items in the broader diet (14, 15). Whether this promotes greater energy
intake remains to be determined.

2.4

Appetite and energy intake

With a few exceptions (16, 17), human feeding trials have shown that nut
ingestion moderates appetite postprandially. Specifically, the inclusion of almonds and
peanuts suppresses hunger (18, 19) and desire to eat (19) and increases fullness ratings
after ingestion (17). Daily consumption of peanuts for 4 d also increased fasting satiety
and fullness levels (20). These are important properties in weight management because a
postprandial reduction in hunger may prolong meal latency; a decrease in desire to eat
may prevent eating in the absence of hunger, and higher fasting satiety and fullness levels
may translate into smaller meal sizes.
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The satiating effects of nuts depend on 2 important factors. First, the form of nuts
exerts differential effects on appetitive sensations. Smaller hunger suppression and
greater hunger rebound (180 min postingestion) were observed when peanuts were
consumed in the form of butter compared with whole nuts (18). However, whole almonds
reportedly induce fullness levels comparable to those of almond butter (17). Second, the
timing of nut consumption can affect appetite. The consumption of almonds together with
a meal does little to augment the appetite-modulating effects of that meal, whereas
consuming almonds alone as snacks blunts hunger and desire-to-eat ratings compared
with individuals who received no nuts (19, 21). Other work noted that the ingestion of
peanuts or peanut-containing snacks (300 kcal/d) tended to induce greater energy
compensation when ingested as snacks relative to when they were consumed as part of a
lunch meal (22). Hence, the form and timing of nut consumption may modulate
appetitive sensations, with suggestive evidence that satiation/satiety effects may be
greater for whole nuts consumed as snacks.
The underlying mechanisms for the appetitive effects of nut consumption are not
well understood due to a paucity of studies on the issue. However, the available evidence
indicates that the satiating effects of nuts are not likely to be mediated by delayed gastric
emptying (23) or the release of selected appetite-regulating gut peptides including
glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), or
ghrelin (10, 17, 20). However, the effect of nut consumption on protein YY (PYY)
secretion is mixed (10, 20). Furthermore, feeding 3 g of pine nut oil (in the form of fatty
acids or triglycerides) reportedly decreased prospective food-intake ratings and increased
the secretion of cholecystokinin (CCK) (11). Together, these studies suggest that the
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satiating effects of nuts may be mediated by CCK and/or PYY secretion and that this
effect may stem from the dietary protein or fat content of nuts. Their high unsaturated fat
content has been proposed as the primary driver of satiety (24, 25). This hypothesis was
based on evidence that unsaturated fat is oxidized more readily than saturated fats (26)
and so would generate a more rapid and stronger satiety cue. However, several trials have
directly tested this hypothesis and have not provided experimental support (27 30).
An expectation of appetite modulation by nuts is that it will translate into reduced
energy intake from the balance of the diet by evoking a strong compensatory dietary
response. Compensation data from trials that used almonds (31 33), hazelnuts (34, 35),
macadamia nuts (36), peanuts (37, 38), pecans (39, 40), pistachios (41, 42), and walnuts
(43) suggest that values range from 54% to 104% (18, 31, 33, 37). Thus, the majority of
the energy provided by nuts is offset by spontaneous adjustments in the total diet. Dietary
compensation may depend on the form of nuts consumed. Peanuts, in the form of peanut
butter, produced higher dietary compensation than whole peanuts (104% compared with
151%) (18), despite evoking a weaker satiety effect (44). In summary, nut ingestion
suppresses hunger and desire to eat and promotes fullness. These sensations may aid
dietary compensation that offsets much of the energy contributed by nuts. However,
strong compensation can also occur independently of reported appetitive effects. This
may reflect imprecision in appetite measurement or a truly independent uncharacterized
mechanism.
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2.5

Mastication and the efficiency of nutrient absorption

Although the nutritive value of nuts is well documented, a growing body of
evidence indicates that the published values may be substantively modified by the nut's
physical properties (45). In particular, the structure and high fiber content of nuts modify
the bioaccessibility and bioavailability of the nutrients they contain. To access the
nutrients in nuts, their parenchymal cell walls must be disrupted. This may occur by
enzymatic or microbial degradation or mechanical processing in the mouth (chewing) and
stomach. The fiber nuts provide may bind with food constituents such as fatty acids,
reducing the efficiency of their absorption (46). Fiber may also alter gastric emptying and
gastrointestinal transit times and gut hormone secretion, with implications for appetite
and energy intake (47). In addition, the cell walls may serve as a source of fermentable
fiber in the colon, affecting energy balance and gut health (48, 49). Because these
dynamic processes will largely determine the nutritional impact of nut consumption, they
are attracting increasing research attention (50).
Nuts require considerable oral processing effort and this may, in part, account for
the often-noted less-than-predicted effect of their consumption on body weight (31, 35,
39, 43). The mechanical act of chewing reportedly generates satiation signals through
cognitive (51), neural (52), endocrine (12, 53), and physical (eg, gastric emptying) (54)
mechanisms; augments cephalic phase responses linked to appetite (55 58); influences
digestion efficiency (12, 59 61); modestly increases energy expenditure (62); and elicits
dietary compensation (63).
A number of studies have evaluated the efficiency of energy absorption from
ground and tree nuts through feeding trials. All showed substantive increases in fecal fat
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loss with nut consumption, although the values ranged widely from 5% to >20% (12,
61, 64 70). One early trial, in which peanut products constituted 95% of daily fat intake,
reported the percentage of dietary fat excreted was 17.8% for whole peanuts, 7.0% for
peanut butter, and 4.5% for peanut oil (68). These results documented a food form effect.
However, there was also an effect of background diet because these fecal fat-loss values
were observed when participants were consuming 20 g crude fiber daily, but decreased to
16.8%, 4.2%, and 1.8% for the 3 peanut forms when the background dietary fiber content
was reduced to 5 g/d. Presumably, there was greater binding of energy-yielding nutrients,
especially fatty acids, to the fiber in the high-fiber condition, leading to greater fecal
excretion. The contribution of background diet to treatment effects may account, in part,
for differences in absorption efficiency across studies. Subsequent work showed elevated
fecal fat excretion with nut consumption across different types of nuts, including almonds
(12, 65, 67, 70), pecans (66), pistachios (69), and peanuts (64). In some (67, 70), but not
all (61, 69), studies, the increment in fecal fat followed a dose-response pattern. In the
latest studies conducted in the same laboratory under comparable conditions, fecal fat
losses associated with 42 g almond and pistachio loads/d were comparable at 4.5 g/d
(61, 69). However, they were higher with almonds (9.1 g/d) compared with pistachios
(6.7 g/d) at higher nut intakes (84 g/d). This suggests relative consistency across nuts
for effects at suggested levels of consumption and possibly a nonlinear dose-response
relation for some types of nuts.
These trials raise a number of nutritional issues. First, the inefficiency of
absorption is a double-edged sword. Whereas this may be beneficial with respect to
moderating energy intake and the possible contribution of nuts to positive energy balance
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and weight gain, it also likely reduces the absorption efficiency of lipid-soluble nutrients
and other macronutrients. Fat accounts for 55% of the increment in fecal energy loss
when nuts are included in the diet (64), so other energy-yielding substances must also be
affected. Vitamin E extraction is lower in whole compared with finely ground and
defatted almonds with added almond oil (45). The availability of all nutrients is increased
with longer gastrointestinal residence time due, in part, to swelling of cell walls and
leakage of nutrients out of the parenchymal cells (45). Consequently, nut form can be
used for selective purposes: that is, consumption of whole nuts when moderating energy
intake is of primary concern; consumption of chopped, sliced, or finely ground nuts or
butter or oils when maximization of nutrient intake is the priority. The delayed absorption
of lipid from whole nuts may also moderate postprandial lipemia (71) and glycemia (17).
Processing of nuts is an additional factor that influences nutrient bioaccessibility (4).
Roasting of almonds leads to smaller fragments with greater bioaccessibility of cell
contents when chewing. Mastication studies of peanuts confirm that the physical
properties of nuts influence their disintegration characteristics (13). They also show that
the matrix in which peanuts are embedded modifies chewing behavior but without
modifying the final nut particle size. Simulated gastric processing of peanuts shows
graded disintegration rates, from the fastest to the slowest in the following order: frying >
roasting > boiling > raw (5).
Second, the data on energy bioaccessibility raise questions about the use of
Atwater conversion factors for nutrient labeling. A goal of labeling based on standardized
servings is to permit consumers to make informed choices about the energy content of
different foods to meet their nutritional goals. The structure of nuts may be different
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enough from other foods to render labels sufficiently inaccurate to warrant another basis
for determination of their energy contribution to the diet (61, 69, 72).
Third, with the introduction of flavorings to nuts to enhance their appeal,
questions have been raised as to whether flavors modify chewing and health outcomes.
Because flavors are applied to the outer surface of nuts, they exert a strong sensory
impact (73) and the actual amount added is limited. Consequently, they would not be
expected to directly influence health risks associated with the flavor principle (eg,
exacerbation of hypertension by sodium or hyperglycemia by sugar). However, they
could theoretically alter oral processing and modify nutrient availability from the nuts
themselves. The limited available data suggest that among the varieties tested (ie, raw,
roasted unsalted, roasted salted, and honey roasted), no effects of flavor were reported on
masticatory outcomes including particle size distribution (74, 75).
Issues of bioaccessibility raise questions about nutrient delivery between types of
nuts. Almonds and peanuts have markedly different hardness. The initial break forces for
almonds and peanuts are reported as follows: raw nut (7442 ± 332 compared with 3046 ±
380 g), honey roasted (5981 ± 172 compared with 1834 ± 232 g), roasted unsalted (5004
± 209 compared with 1545 ± 337 g), and roasted salted (4940 ± 267 compared with 1195
± 289 g) (74, 75). These differences in hardness lead to variation across forms and
between nut types for indexes of oral processing effort such as number of chews,
chewing rate, and time spent chewing, but the end result is a strikingly similar profile of
particle sizes (Figure 2-1). No differences related to BMI have been reported, but
processing effort is stronger in the fasted compared with sated states (74, 75). Thus, to the
extent that particle size proxies for nutrient availability, the present literature suggests
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more commonalities across nuts than differences. This coincides with a large body of
literature showing similar effects of different nuts on cardiovascular disease risk,
postprandial glycemia, and body weight (15, 76 78).

2.6

Energy expenditure

A limited number of trials have explored the effects of nut consumption on
thermogenesis, either postprandially (also known as diet-induced thermogenesis) or on
resting energy expenditure (REE). The fatty acid composition of nuts has been the target
of much of this work. In an acute-feeding setting, the consumption of a meal containing
walnuts (33% of energy from PUFAs) increased diet-induced thermogenesis significantly
when compared with a dairy-containing meal (32% of energy from saturated fat) (16). An
isoenergetic meal containing olive oil (31% of energy from MUFAs) yielded comparable
  

 

    



 

  



attribution of the elevation of energy expenditure and fat oxidation to the higher PUFA
content of the walnut and the higher MUFA content in the olive oil meals cannot be
verified. In addition, the inclusion of almonds [60 g (74) or 54.3 g (31)] and peanuts [52.5
g (37)], both rich sources of unsaturated fats, into meals has not led to elevated
thermogenesis. The acute postprandial thermogenic effect of nuts is yet to be confirmed.
Mixed findings on thermogenesis have been reported from short- and longer-term
(ranging from 4 d to 12 mo) trials of nut consumption. No effects have been documented
with walnuts (20, 79). One study with almonds reported no effect, whereas another
observed an increase that accounted for 14% of the energy contributed by the almonds
(31, 33). Several studies with peanuts have noted an increase in REE. In one trial, there
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was an 11% increase after 8 wk of peanut consumption (52.5 g/d). When lean and
overweight adults were supplemented with peanut oil (as 30% of REE) for 8 wk in
another study, REE was elevated by 5%, but only in overweight individuals (80).
Collectively, there is some evidence that nut consumption increases thermogenesis, but
the data are not robust and there is no clear mechanism. One possibility is that the lipid
from nuts is absorbed over a prolonged period of time, leading to a small but sustained
source of substrate that fuels thermogenesis and could appear as an increase in REE.

2.7

Adipose tissue and fat metabolism

It has been proposed that nut consumption elevates fat oxidation and
preferentially reduces body fat mass, especially in the viscera. These actions are
attributed to their high unsaturated fat content. If true, their inclusion in the diet could
help to prevent or mitigate the effects of metabolic syndrome. Animal studies have shown
that higher PUFA intakes suppress adipocyte differentiation and downregulate adipocyte
P2 and adipsin genes (81). However, PUFAs did not have an effect on adipose tissue size
(82). In rodent retroperitoneal (but not subcutaneous) adipose tissues, fatty acid synthase
(FAS), hormone-sensitive lipase (HSL), phosphoenolpyruvate carboxykinase (PEPCK),
  

    

    

mRNA concentrations decrease with higher PUFA intake, suggesting targeting of the
visceral fat pool (82). There are also indications that fat metabolism is enhanced by
higher PUFA intake (83). Mitochondrial protein gene expression is upregulated in the
epididymal fat of mice fed PUFAs (84). The expression of genes that regulate oxidative
metabolism [eg, peroxisome proliferator-  
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factor 1 (Nrf1)] are also elevated (84).
In one acute-feeding study, a high-PUFA diet (33% of energy) enriched with
walnuts increased fat oxidation in humans (albeit not significantly) (16). In another study,
fat oxidation was significantly elevated (50% higher compared with a control diet)
when 3035 g of walnuts were ingested by overweight and obese adults (85). The
stronger effects noted in this trial may reflect the difference in participant BMI status.
Blunted fat oxidation has been reported in adults with high body weight (86), but the
inclusion of walnuts appears to reverse or normalize impaired fat oxidation. Notably, in
the latter study, the dietary fat concentration and the composition of fat subtypes were
matched, suggesting that the fat-oxidizing property of walnuts was not limited to their
PUFA content alone. There are no human studies of fat oxidation with other nuts, which
limits extrapolation of the walnut findings. Other nuts are richer sources of MUFAs
compared with the high PUFA content of walnuts, and MUFAs are reported to induce
comparable or higher fat oxidation rates (87, 88). This suggests that equal or greater
effects on fat oxidation may be expected with other nuts.
Several clinical trials have examined whether elevated fat oxidation induced by
walnuts translates into fat mass loss over time. In one trial (89), the inclusion of walnuts
in a weight-maintenance diet of type 2 diabetic adults led to a small reduction in body fat,
although body weight remained stable during the 6-mo study period. Body fat increased
in individuals who adhered to the control diet (low-PUFA), and the difference between
the groups approached significance (P = 0.057). The trend persisted when the
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intervention period was extended to 1 year, where the inclusion of walnuts produced
greater fat mass loss relative to the control group despite comparable weight in the groups
(79). Early evidence suggests that the loss of fat mass derived predominantly from the
subcutaneous and less from the visceral fat pools, although the size of both fat depots
decreased over time in the walnut group (79). The effects of PUFAs on different body fat
pools have been studied more intensively with the use of animal models (81, 90 95). This
work consistently shows that higher PUFA intake reduces visceral fat. However, findings
in humans, to date, do not replicate these results (79). Indeed, just the opposite has been
reported, in which PUFAs appeared to preferentially reduce subcutaneous fat. No
explanation for the inconsistent outcomes between human and rodent studies is apparent.
Because subcutaneous and visceral fats are part of total body fat, evidence has shown that
visceral fat loss is primarily determined by total fat mass loss (96). Human studies
incorporating different nuts into the diet at realistic doses are needed to determine the
effect of nut consumption on body composition. Findings may yield insights for
management of body fatness and risk of metabolic syndrome.

2.8

Nut consumption and body weight

The literature on nut consumption and body weight has been the topic of several
reviews (76, 97 104). Generally, epidemiologic studies indicate that incorporating nuts
into diets on a regular basis does not compromise, and may aid, weight maintenance (14,
105 111). Because energy balance is the ultimate determinant of body weight, not
surprisingly, controlled feeding studies using almonds, walnuts, pecans, and macadamia
nuts all indicate that nut consumption does not cause changes in body weight when
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energy intake is continually adjusted (14, 40, 112 115). More important, when total
energy intake is less controlled, studies that involve the inclusion of nuts in habitual diets
of free-living individuals have also shown that nut consumption does not lead to weight
gain (36, 116 119). However, it must be noted that these were relatively short-term trials
with limited power to detect small changes in body weight. Although there are reports of
small, but significant increases in body weight with nut consumption (30, 120 122), the
preponderance of evidence indicates that under controlled or free-living situations, nut
consumption does not promote weight gain.
Several studies assessing the role of nut consumption in weight-maintenance
programs have noted a decrease in body weight from baseline (32, 36, 40, 79, 113, 114).
Whether this is due to a greater thermic effect of food or REE effect of the nuts compared
with the foods they displaced in the diet has not been established. Nevertheless, current
data indicate that the inclusion of nuts in a weight-maintenance program will not lead to
weight gain and may aid weight loss.
The inclusion of nuts in energy-restriction regimens does not impede weight loss
(115, 123 126). In several trials in which nuts did not augment weight loss (125, 126),
there was a reduction in cardiovascular disease risk indexes in the nut-consuming groups,
suggesting that such benefits derive from properties of the nuts rather than just weight
change. There is a need for long-term randomized intervention studies with body weight
as a primary outcome to establish the effect of nuts consumed daily in realistic quantities
on maximal and sustainable weight loss.
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2.9

Conclusions

It is now well established that body weight and fatness are functions of energy
balance rather than the macronutrient content of the diet (125, 127, 128). Nuts are a highfat, energy-dense food, but the evidence indicates that they pose little challenge to and
may even aid weight management. This is attributable to the strong dietary compensation
effects they elicit, inefficiency in the absorption of the energy they provide, and possibly
an elevation of energy expenditure and fat oxidation. Although energy is the determinant
of body weight and composition, the greater health effects of diets will be determined by
their macronutrient content and other constituents. Nuts are rich sources of unsaturated
fats, minerals, vitamins, antioxidants, and fiber, which can contribute to a healthful diet.
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Table 2-1: A summary of recent trials on human energy balance using a variety of nuts
Type of nut and
first author (ref) Year

Design

Length

n

Treatments

EI Appetite

Fat
absorption

Diet
compensation

Fat
EE oxidation

Weight

Body fat

Almonds
Kirkmeyer
(18)

Randomized,
2000 crossover

180 min
and 24 h

24

500 kcal almonds vs no load
condition and preloads matched
on weight and volume

Fraser (31)

Randomized,
2002 crossover

6 mo

81

320 kcal almonds/d vs no almonds



Jenkins (32)

Randomized,
2002 crossover

4 wk

27

22.2%E from almonds or 11.1%E
from almonds + 11.1%E from
muffins vs 22.2%E from muffins



Wien (115)

RCT weight
2003 loss

24 wk

65

84 g almonds/d vs isocaloric
complex carbs

Hollis (33)

Randomized,
2007 crossover

10 wk

20

344 kcal almonds/d vs no almonds

14

43 g almonds vs no almonds,
almond flour, and almond oil
groups, all matched on 75 g
available carbohydrate in
breakfast meals

Randomized,
2011 crossover

Mori (17)

490 min

Novotny ( )

Randomized,
2012 crossover

18 d

18

42 and 84 g almonds/d vs no
almonds

Foster (125)

RCT weight
2012 loss

18 mo

123

56 g/d vs no almonds

Tan (19,21)

2012 RCT (suppl)

4 wk

137

43 g/d vs no almonds

61



57%



54 78%










74%


















Fullness
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Table 2-1 continued
Type of nut and
first author (ref) Year Design

Fat
absorption

Diet
compensation

Fat
EE oxidation

Length

n

Treatments

EI Appetite

Weight

Randomized,
2007 crossover

4 wk

15

40 g hazelnuts/d vs low-fat diet
(no hazelnuts)





Prospective
2010 (suppl)

4 wk

21

1 g hazelnuts/kg per day





Prospective
2003 (suppl)

4 wk

17

4090 g/d (15%E from
macadamia nuts)

24

500 kcal peanuts and PB vs no
load condition and preloads
matched on weight and volume

30 wk

15

500 kcal peanuts/d: FF vs ADD
vs SUB

Body fat

Hazelnuts
Mercanligil
(34)
Yücesan (35)
Macadamia
nuts
Garg (36)



Peanuts
Kirkmeyer
18
( )

Randomized,
2000 crossover

180 min
and 24 h

Peanuts: 104%;
PB: 151%





Alper (37)

2002 Crossover

Griel (14)

2004 Epidemiology

NS

14,262

Traoret (64)

Randomized,
2008 crossover

79 d

16

70 g peanuts/d vs no peanuts

Devitt (22)

Randomized,
2011 crossover

300 min

66

300 kcal peanuts vs isocaloric load 

8 wk

19

68 g pecans/d



66% (FF)





 (SUB,
 
(ADD)

Negative
assoc

Users vs nonusers







Pecans
Morgan

(39)

Prospective
2000 (suppl)
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Table 2-1 continued
Type of nut and
first author (ref) Year Design

Rajaram (40)

Length

n

Treatments

EI Appetite



Randomized,
2001 crossover

4 wk

23

20%E from pecans vs no pecans,
both treatments as part of Step 1
diet

Prospective
2006 (suppl)

3 wk

44

20%E from pistachios

4 wk

15

15%E from pistachios vs no
pistachios

12 wk

59

53 g pistachios/d vs 56 g
pretzels/d

Fat
absorption

Diet
compensation

Fat
EE oxidation

Weight

Body fat



Pistachios
Kocyigit (41)

Randomized,
Sheridan (42) 2007 crossover






Li (123)

RCT weight
2010 loss

Baer (69)

Randomized,
2012 crossover

3 wk

18

42 and 84 g pistachios/d vs no
pistachios

2001 Crossover

6 wk

18

48 g walnuts/d vs no walnuts



Tapsell (89)

RCT weight
2004 maintenance

6 mo

58

30 g walnuts/d vs no walnuts





 

Sabaté (120)

Randomized,
2005 crossover

6 mo

90

28 56 g/d (12%E from walnuts)
vs no walnuts







Almario

(43)





  
    
g)



Walnuts

5h

29

Randomized,
2009 crossover

8h

16

30 g walnut-enriched meal vs
olive oil enriched isocaloric meal

Tapsell (85)
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CasasRandomized,
Augustench (16) 2009 crossover

33%E PUFAs from walnutenriched meal vs olive oil
(MUFAs) and dairy product
(saturated fat) enriched isocaloric
meals
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Table 2-1 continued
Type of nut and
first author (ref) Year Design

Length

n

Treatments

EI Appetite


Tapsell (79)

RCT weight
2009 maintenance

12 mo

50

30 g walnuts/d vs lower-fat diet
(no walnuts)

Brennan (20)

Randomized,
2010 crossover

4d

20

48 g walnuts/d vs isocaloric
placebo



3 g pine nut FFA or 3 g TGs vs 3
g placebo (olive oil), all in
combination with breakfast



Fat
absorption

Diet
compensation

Fat
EE oxidation

Weight

Body fat



 




Pine nuts
Randomized,
2008 crossover

240 min

18

2001 Epidemiology

12-y
followup

34,111
women

Eating frequency per week

Negative
assoc (NS)

Albert (106)

2002 Epidemiology

12-mo
followup

21,454
men

Eating frequency per week

No assoc

BesRastrollo (107)

2007 Epidemiology

Median
28 mo

8865

Eating frequency per week

Negative
assoc

Mozaffarian
(111)

2011 Epidemiology

NS

Pasman (11)
Nut not
specified
Ellsworth
(108)

Negative
assoc

120,877 Serving size

ADD, added to diet; assoc, association; EE, energy expenditure; EI, energy intake; FF, free feeding; FFA, free fatty acids; PB, peanut butter;
RCT, randomized controlled trial; ref, reference; SUB, replaced equal amount of fat in diet; suppl, supplement; TG, triglyceride;
,significantly

higher; , significantly lower,

, no change; %E, percentage of energy;

, did not measure
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Figure 2-1: Particle sizes (in mm) of raw, salted, roasted, and honey roasted almonds and
peanuts after mastication.
The x axis indicates the size of particles after mastication before swallowing.
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CHAPTER 3. A LITERATURE REVIEW ON THE EFFECTS OF NUT
CONSUMPTION ON BODY COMPOSITION, CARDIOVASCULAR HEALTH
AND COGNITIVE FUNCTION

3.1

Introduction

Nuts are high in vegetable protein, fiber, monounsaturated fats (MUFAs),
polyunsaturated fats (PUFAs), polyphenols, phytosterols and many vitamins and
minerals(1); nutrients that have beneficial effects on cardiovascular health and cognitive
function. This chapter explores the literature on the effects of nut intake on other
outcomes of the dissertation research such as body composition, specifically visceral fat,
vascular health, lipid profile, glycemic control and cognitive function(1,2). The potential
role of nut consumption in ameliorating the post-lunch decline in cognitive function is
also discussed.

3.2

Nut consumption and body composition

Epidemiological evidence indicates that nut consumption is associated with better
adiposity measures(3). Moreover, a recent meta-analysis of controlled interventional trials
found that nut intake does not increase adiposity and, in fact, had an inverse effect on
adiposity for interventions that imposed energy restriction compared to those focusing on
weight maintenance(4). This meta-analysis included trials that assessed adiposity using
anthropometric measures such as BMI and waist circumference. Very few trials have
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used direct measures to assess changes in adiposity after nut consumption and have
reported conflicting results. While one weight-loss intervention noted that almond
consumption for 24 weeks was associated with greater reductions in fat mass when
assessed using bioelectrical impedance(5), another weight-loss trial of the same duration
observed reductions in DEXA-assessed fat mass with almond consumption which were
similar to that of the control(6). Moreover, the Multi-Ethnic Study of Atherosclerosis
(MESA) demonstrated that nut consumption was associated with decreased adiposity (as
assessed by computed tomography (CT)) but only in the pericardial area and not in the
subcutaneous and visceral depots(7).
Visceral obesity is correlated with various cardio-metabolic disorders and obesityrelated complications. However, very few trials have examined the differential effects of
nut consumption on subcutaneous and visceral fat loss. Two nut-based interventional
trials have examined VAT directly and reported conflicting findings(8,9). While one trial
in diabetic individuals observed that walnut consumption led to significant reductions in
fat in both visceral and subcutaneous depots(8), the other trial in individuals with
metabolic syndrome found no reduction in visceral or subcutaneous adipose tissue
(assessed by MRI) with pistachio consumption for 24 weeks(9). Other studies have
assessed overall abdominal obesity, but not VAT specifically. For example, in a 6- week
crossover trial, almond consumption resulted in greater reductions in abdominal fat in
individuals with elevated LDL-C compared to a control diet(10). Hence, there are very few
nut-based trials assessing VAT using direct measures such as DEXA, MRI or CT scans
and no almond-based trials that have assessed VAT directly in the context of energyrestriction.
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3.3

Nut consumption and vascular health

Dietary patterns that incorporate nuts such as the Mediterranean diet, DASH diet
and the Nordic diet are associated with decreased blood pressure(11). Nuts are high in Larginine (2-3g arginine/100g), a precursor for nitric oxide which increases endothelialdependent dilation. Nuts are also rich in K and Mg which could assist in reduction of
blood pressure. However, findings from nut-based clinical trials are somewhat mixed.
While one meta-analysis investigating cardiovascular outcomes after tree nut
consumption suggests no effect of tree nuts on resting blood pressure in individuals
without prevalent CVD(12), another meta-analysis published in the same year found that
nut consumption led to reductions in systolic blood pressure but only in non-diabetic
individuals(13). The heterogeneity in the study inclusion criteria and analyses between the
two meta-analyses could have led to the discrepant findings. The tree nut meta-analysis
excluded peanuts from the analysis and standardized the effect size to 1 oz. of nuts per
day(12). In contrast, the other meta-analysis included all tree nuts, peanuts and soy nuts in
the analysis and did not standardize the nut dose response(13). Nevertheless, the
preponderance of clinical evidence shows the greatest effects of nuts on blood pressure in
individuals with some CVD risk factor. For example, peanut consumption for 12 weeks
was associated with reduction in diastolic blood pressure in individuals at high CVD
risk(14). Moreover, in the PREDIMED trial, consumption of a nut-based Mediterranean
diet for one year led to a decrease in 24-hour ambulatory systolic and diastolic BP but
only in high CVD risk individuals(15). Although there is some data to suggest that almond
consumption in the context of energy restriction may augment reductions in blood
pressure(5,16) it is not well characterized.
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Nut consumption may also have beneficial effects on other indices of vascular
health such as endothelial function and arterial compliance. A literature review indicates
that nut consumption results in a 19.7% relative increase in vasodilation when computed
as weighted average change across 9 studies(2). Although there are benefits, particularly
with walnut consumption, conclusions for other types of nuts cannot be quantified. There
is limited evidence regarding the effects of nut consumption on arterial compliance.
While 40g of pistachio consumption for 3 months led to reduced arterial stiffness(17), 15g
of walnut consumption for 4 weeks did not(18) suggesting perhaps a dose-dependent
and/or long-term response. Walnuts are the most extensively researched nuts and are high
in ALA which is associated with improved endothelial function and neuro-protective
effects in animal models(2). Almonds and pistachios are high in MUFAs which also
reduce arterial stiffness(19) and endothelial dysfunction(20). In general, the cholesterol
lowering effects of nuts can reverse endothelial dysfunction as hypercholesterolemia
impairs endothelial function(21). This may have important implications for cognitive
function as discussed later.

3.4

Nut consumption, lipids and inflammation

Nut consumption promotes cholesterol-reduction(22) and reduces cardiovascular
risk factors, inflammation and oxidative stress(23). The preponderance of nut-based
evidence shows the greatest improvements in blood cholesterol in individuals with high
LDL cholesterol and those with low BMI. Improvements in triglycerides are greatest in
individuals with hypertriglyceridemia(22). The cholesterol lowering effects of nut
consumption appear to be dose-dependent with consumption of 60g of nuts or more per
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day having the greatest effects(12). Nut consumption is also associated with reductions in
inflammatory markers such as CRP, IL-6, ICAM-1, VCAM-1, E-selectin and interleukins
(2)

. These effects too appear to be dose dependent with doses greater than 30g per day

having beneficial effects(2). In addition, when nuts replace olive oil in Mediterranean
diets, improvements in some inflammatory markers are demonstrated(24

26)

suggesting

that nuts have beneficial effects over and above that of the traditional olive oil
Mediterranean diet.

3.5

Nut consumption and glycemic control

Several epidemiological studies have demonstrated a protective effect of nut
consumption on diabetes risk(27,28). Evidence from these studies has led many researchers
to conduct trials investigating the effects of nut consumption on glycemic control. The
regulation of glycemia is a critical factor in reducing the risk of diabetes. Nut
consumption improves postprandial glycemic control in a dose-dependent manner(29

32)

.

In addition, nut consumption has second-meal effects on glycemic control(33,34). The
second meal effect is a phenomenon where a prior meal attenuates postprandial blood
glucose responses to a subsequent meal(35,36). The form of nuts may determine the
accessibility of lipids leading to differential effects on glycemic control(33,34,37). For
example, lipids in more processed forms of almonds such as almond meal and almond
butter are more accessible for absorption than lipids in whole almonds(38,39). Hence,
altering the physical form of nuts may have metabolic effects that warrant further study.
Although the findings from studies examining the chronic effects of nut
consumption are inconclusive, evidence indicates that nut consumption for 12 weeks or
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longer has beneficial effects on glycemic control through improvements in insulin
sensitivity and/or beta-cell function(40,41) and HbA1c concentrations(24,42,43). In contrast,
short-term studies(44

47)

suggest that the consumption of nuts for periods less than 12

weeks may not be effective in enhancing overall glycemic control or measures of insulin
sensitivity. Although nut consumption when eaten alone or as a part of meals, has
positive effects on glycemic control(1), the long term effects are typically more favorable
in prediabetic(41), and diabetic individuals(42) or those with metabolic syndrome(40).

3.6

Nut consumption and cognitive function

Epidemiological evidence indicates beneficial effects of nut consumption on
cognitive function, but mostly in middle aged and older adults. A five year prospective
cohort study found a positive association between nut consumption and cognitive
performance(48). The difference in cognitive performance between the lowest and highest
consumers of nuts was equivalent to a 5 to 8 year age difference(48). In addition, they
found no cognitive decline in the highest nut consumers over 5 years (amount of nuts
unspecified). In the PREDIMED study, walnut (but not other nuts) consumption was
associated with increased working memory in adults aged 55-80 years(49). In another
cross-sectional study, nut consumption was associated with increased executive function
and semantic memory in older adults, although the association was non-significant(50). A
 

   



   

      



  

 

higher long-term nut intake was associated with better cognitive outcomes(51). In addition,
women who consumed more than 5 servings of nuts per week had higher scores than
non-consumers; the difference in scores was equivalent to the difference found in women
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2 years apart in age. The only interventional trial conducted exclusively in young adults
observed an 11% increase in inferential verbal reasoning after consumption of 60g
walnuts/day for 8 weeks(52). They observed no changes in non-verbal reasoning and
memory scores. Another trial observed improvements in working memory and speed of
processing with nut-supplemented diets in the context of energy-restriction(53). The
effects of almond consumption on the memory and attention domains of cognitive
function in energy-restricted adults has not been explored before.
The beneficial effects of nuts on cognitive performance are likely due to the
improvements in cardiovascular risk factors such as lipid profile, arterial compliance,
glucoregulation, oxidative stress, blood pressure and inflammation, with subsequent
improvements in endothelial function and cerebral vascular function(2). Improved
endothelial function is important for regulating cerebral blood flow to deliver nutrientrich blood to the brain. Researchers have hypothesized that cognitive performance can be
improved by improving cerebral blood flow(54,55).

3.7

Potential role of nut consumption on the post-lunch dip in cognitive function
Although there are circadian variations in cognitive performance during the day

time, there is an acute decrease in cognitive performance around midday, particularly
after lunch(56). This post-lunch dip in cognitive performance is a well-established
phenomenon of decreased cognitive function in the early afternoon hours typically after
lunch consumption. It is thought to begin approximately one hour after the start of lunch
consumption(57). During the post-lunch dip, memory and vigilance are the most severely
affected domains, and decreased mood, alertness and anxiety are also reported(58,59).
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These symptoms may negatively affect performance and increase personal and societal
risks(57,60,61). A dip in cognitive function after lunch may be caused by an increase in
cortisol levels(62), insulin surges(63) and increased serotonin levels(64). Although there are
no studies investigating the effects of nut consumption on the post-lunch dip, nuts can
potentially affect cognitive function post-prandially by manipulating the macronutrient
composition of the meal. Lunch composition is reported to play a role in the post-lunch
dip with high-fat lunches leading to slower(65,66) but more accurate(66) responses than lowfat lunches. High-carbohydrate meals are shown to have a sedative effect promoting
drowsiness in females and calmness in males(64). Moreover, high carbohydrate and low
protein meals could increase brain serotonin levels that could affect cognitive function(64).
The unique nutrient composition of nuts such as almonds which are higher in fat and
protein and lower in carbohydrate may ameliorate this post lunch dip in cognitive
function.
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4.1

Abstract

Background: Inclusion of almonds in an energy restricted diet has been reported to
enhance or have no effect on weight loss. Their effects specifically on visceral body fat
stores (VAT) during energy restriction have not been widely examined. Additionally,
almond consumption has been associated with reduced blood pressure (BP), but whether
this is linked to or independent of changes of body composition has not been examined.
Objective: To evaluate the effects of consuming almonds as part of an energy-restricted
diet on body composition, specifically visceral adipose tissue and blood pressure
compared to a nut-free energy restricted diet.
Methods: Eighty-six healthy adults (BMI: 25-40 kg/m2) were randomly assigned to a 12
week energy restricted (500 kcal/d deficit) almond-enriched diet (AED) or a comparably
energy restricted nut-free diet (NFD). Participants in the AED group consumed almonds
providing 15% of energy in their individualized energy-restricted diet. Participants in the
NFD group avoided nuts during the energy restriction period. This study is registered on
ClinicalTrials.gov (registration number: NCT02360787)
Results: Body weight, trunk fat percent, total fat percent, VAT and systolic BP decreased
after 12 weeks of energy restriction (P<0.05). Compliant participants in the AED group
had a greater reduction in trunk and total fat percentages (P<0.05), diastolic BP (P<0.05)
and a greater trend for VAT loss over time compared to those in the NFD group (P<0.05).
Conclusions: Inclusion of almonds in a weight loss regimen resulted in greater
proportional reductions of trunk and total body fat as well as diastolic blood pressure
compared to a nut-free weight loss regimen. Hence, moderate almond consumption
during energy restriction may help to reduce metabolic disease risk in obesity.
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4.3

Introduction

Despite their high energy content, the inclusion of almonds in an energy-restricted
diet does not compromise and may enhance weight loss (1 3). This may occur by several
mechanisms, but probably most importantly through improved dietary compliance. This
is likely attributable to greater sensory variety resulting in higher palatability of the diet
(4); stronger locus of control (5) leading to a sense of empowerment; and management of
appetitive sensations through their slow and sustained energy release (6).The satiating
effects of almonds may prolong inter-meal intervals, promote smaller meal sizes and
reduce the desire to eat when not hungry and, hence, contribute to purposeful weight loss
(7).
A goal of weight loss is to maximize the reduction of fat mass while retaining fatfree mass. Traditionally, exercise was viewed as the primary way to achieve this
outcome, but evidence shows that dietary factors can be equally or more effective.
Increasing the proportion of protein in an energy-restricted diet enhances satiety, energy
expenditure and greater relative fat mass loss (8). In addition, different types of dietary
fat may influence substrate oxidization. Monounsaturated fats are oxidized preferentially
(9,10), and a diet higher in the unsaturated: saturated fat ratio may reduce subcutaneous
adipose tissue (SAT) (11), but more importantly, visceral adipose tissue (VAT) during
weight loss (12). Few studies have investigated the effects of dietary fatty acid
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composition on abdominal fat changes (13). VAT undergoes rapid lipolytic activity
leading to increased liver fatty acid production. As a consequence, muscle insulin
sensitivity reduces and insulin secretion is stimulated. Elevated peripheral insulinemia
will suppress lipolysis and promote lipogenesis, resulting in the accumulation of more
abdominal and visceral fat (14). The preferential loss of VAT is believed to minimize
metabolic syndrome and hence improve metabolic fitness. Almonds are good sources of
protein and monounsaturated fats and their effects on visceral body fat loss, in
conjunction with energy restriction, have not been widely examined.
Being overweight increases the risk of hypertension by 46% to 75% (15). There
is evidence implicating visceral adiposity as the primary cause of obesity-related
hypertension (16). Losing weight may reduce blood pressure and this may be augmented
by incorporating almonds into the diet. Additionally, food-derived peptides such as
arginine reduce the risk of cardiovascular disease (17). Arginine is the physiological
precursor of nitric oxide; a vasodilator (18). Nitric oxide inactivation increases blood
pressure (19). Certain nuts and seeds are good plant-based sources of arginine and studies
with peanuts (2.8g arginine per 100g peanuts, as indicated in the USDA National
Nutrient Database) reveals their ingestion for 12 weeks leads to significant reductions in
diastolic blood pressure (20). Almonds also contain a high level of arginine (2.4g
arginine per 100g almonds), but their effect on blood pressure is not well characterized.
The purpose of this study was to evaluate the effects of almond consumption as
part of an energy-restricted diet on weight, body composition, visceral adipose tissue and
blood pressure compared to a nut-free diet matched on the level of energy restriction. We
hypothesized that inclusion of almonds in an energy-restricted diet will augment the rate
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of weight loss, lead to greater fat loss especially in the visceral depot and reduce blood
pressure compared to a control diet matched on energy-restriction.

4.4
4.4.1

Methods
Participants

Eighty-six (21 men and 65 women) healthy adults (18 60 y/o) with overweight
and obesity (BMI: 25-40 kg/m2) were recruited. Eligibility criteria included the
following: no nut allergies, willingness to consume almonds, not taking medications
known to influence metabolism and appetite, non-smoker >1 year, consistent diet and
 



              

  

registered on ClinicalTrials.gov (registration number: NCT02360787). All procedures
involving human subjects were approved by the Purdue Institutional Review Board.
Participants were recruited via public advertisements. After expressing interest, potential
participants were asked to complete health and personality questionnaires. Participants
were excluded from the trial if they had diabetes or pre-diabetes, uncontrolled
hypertension, cardiovascular disease or dyslipidemia requiring drug therapy. Informed
consent was obtained from participants who met eligibility criteria prior to
commencement of study visits. All participants were compensated for their time and
effort.

4.4.2

Study protocol

The study was a 12-week randomized, controlled, parallel-arm clinical trial.
Participants were randomized into one of two energy-restricted study arms: Almond-
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enriched diet (AED) or nut-free diet (NFD). Both groups received dietary counseling
using the MyPlate food guidance system (21) to reduce energy intake to achieve 500
kcal/day deficit to support weight loss. Their estimated energy requirement was
calculated using the Schofield equations (22) with a physical activity level factor of 1.3.
Participants met with a dietitian on a weekly basis for the first 4 weeks to establish their
dietary prescription, and every 2 weeks after that to monitor dietary adherence. Weekly
energy and nutrient analyses using 24-hour food recalls were conducted to determine
  

 

   

   

      



maintain their usual physical activity habits throughout the study duration. Compliance to
physical activity was tracked every 4 weeks on 2 days: one weekday and one weekend
day, using a previously validated triaxial accelerometer (RT3, Stayhealthy Inc., USA)
(23).
Forty-three participants were randomized into the AED and NFD groups each.
They were asked to consume dry-roasted, lightly salted almonds providing 15% energy in
their individualized energy-restricted diet. Energy from almonds was accounted for
during dietary modeling so that a 500 kcal/day deficit was achieved. Participants in the
AED group were asked to avoid consumption of other nuts and seeds. Participants in the
NFD group were asked to avoid all nuts, seeds and nut products during the intervention
period.

4.4.3

Study outcomes

The primary outcomes for this study were weight, body composition, visceral
adipose tissue and resting blood pressure. Other outcomes were waist circumference,
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sagittal abdominal diameter, serum lipids, insulin, glucose, 24-hour ambulatory blood
pressure and 24-hour free-living appetite. All outcomes were assessed at baseline and 12
weeks after the intervention.

Anthropometric outcomes
Body weight was measured using a calibrated scale (Model ABC, Tanita Inc.,
USA) with participants wearing minimal light-weight clothing. Height was measured
using a wall-mounted stadiometer. Body composition was assessed using dual-energy Xray absorptiometry (Lunar iDXA, GE Healthcare, UK). Sagittal abdominal diameter
(SAD) was measured using a portable sliding caliper (Holtain-Kahn Abdominal Caliper,
Holtain Limited, UK) placed at the level of the iliac-crest while participants were in a
supine position. Waist circumference was measured using a measuring tape placed at the
narrowest part of the torso.
VAT was predicted using two multivariate anthropometric models. The first
model was based on proximal thigh circumference, waist circumference, age and/or BMI
(24) i.e. women: VAT = 2.15 (waist circumference, cm) - 3.63 (proximal thigh
circumference, cm) + 1.46 (age, y) + 6.22 (BMI, kg/m2) - 92.713; men: VAT = 6 (waist
circumference, cm)

4.41 (proximal thigh circumference, cm) + 1.19 (age, y)

213.65(24) (model 1). Proximal thigh height was measured using a measuring tape placed
around the thigh just distal to the gluteal crease. The second model was based on sagittal
diameter, age, waist circumference and trunk fat % i.e. VAT = -208.2 + 4.62 (sagittal
diameter, cm) + 0.75 (age, y) + 1.73 (waist circumference, cm) + 0.78 (trunk fat, %) (25)

70
(model 2). Although this model has only been validated for women, we applied it for men
as well and examined the correlations between the 2 models with regard to sex.
Resting blood pressure was assessed using an automated digital blood pressure
monitor (Model 6013, American Diagnostic Corporation, USA). The participants rested
for 5 min prior to blood pressure measurement. Three readings were taken and the
average was used to determine resting blood pressure. Twenty-four hour ambulatory
blood pressure in a free-living environment was assessed using an automated ambulatory
blood pressure machine (ABPM50, Contec, China) that was programmed to measure
blood pressure every hour from 8 am to 12 am then every 4 hours till 8 am the next day.
This device was worn on the arm for 24-hours and the cuff periodically inflated and
deflated to measure blood pressure.

Serum lipids, insulin and glucose
Fasting blood samples (8ml) obtained from participants were analyzed for serum
lipids (total, LDL and HDL cholesterol and triglycerides), insulin and glucose using an
automated sample analyzer COBAS (COBAS integra 400 plus, Roche Diagnostics
Limited, USA).

24-hour free living appetite ratings
Hunger, fullness, desire to eat and prospective consumption ratings were
measured on 100-mm visual analog scales on   
            



     

          

period. The mean of the respective appetite ratings were considered for analysis.
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4.4.4

Almond acceptance and palatability

Participants randomized to the AED group rated the acceptability of almonds
using a food action rating scale (26) and the palatability of almonds using a hedonic
general labelled magnitude scale (gLMS) (27,28) one week after the start of the
intervention and at the end of the intervention.

 

4.4.5

Compliance assessment

  

      

via self-reported intake (24-  

      

    
  



 

to their respective intervention groups (i.e. almond consumption or no nut consumption)
was monitored via self-reported intake as well as by analyzing their erythrocyte
membranes for lipids and flavonoids at baseline and 12 weeks after the intervention.
The lipid extracts from participant   

           

Rose and Oklander (29) and were analyzed by a shotgun lipidomics approach (J Dhillon,
CR Ferreira, TJP Sobreira, unpublished data). The most informative lipids identified
through the lipidomics scans and nut flavonoids reported in literature were combined into
two MS methods i.e. single ion monitoring (SIM) and multiple reaction monitoring
(MRM) using a triple quadrupole mass spectrometer. Data obtained from the targeted
SIM and MRM methods were analyzed via univariate (volcano plots) and multivariate
(PCA) statistics using Metaboanalyst (version 3.0, 2015) (30). The performance of the
different m/z values and their combinations and ratios was evaluated by receiver
operating characteristic (ROC) analyses.
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4.4.6

Statistical analysis

We conducted two analyses, a primary intention-to-treat analysis followed by a
secondary analysis of participants compliant to their respective intervention groups. Both
analyses used a linear mixed model with time, intervention group and a time-byintervention group interaction as factors for all absolute values of outcomes. An
additional linear mixed model analysis on the change in outcomes as opposed to absolute
values was also performed. In each analysis, when significant interactions were observed,
pairwise comparisons with Bonferroni correction were carried out. Age range, sex and
BMI range were also considered as between-subject factors for all the tests but there were
no effects of the aforementioned factors on any of the outcomes.
The sample size calculations for this study were based on detection of a 7%
difference in visceral fat between groups with 80% power and a 2-tailed alpha of 0.05.
Complete data were required from forty participants per group.
Between-group differences were assessed at baseline by using independentsamples t tests. Categorical outcomes were assessed using chi-square tests. The alpha
level was set at 0.05. SPSS (version 22, 2013, SPSS Inc.) was used for all the statistical
analyses. Data are reported as means and standard errors (SEM) unless otherwise stated.

4.5
4.5.1

Results
Participants

Eight-six participants enrolled in the study, but 7 withdrew during the intervention
(Figure 4-1). The attrition rates were 7% for the AED group and 9.3% for the NFD group
at 12 weeks. There were no significant differences in attrition between the AED and NFD
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intervention groups at 12 weeks (P=0.69). The baseline characteristics of all participants
are described in Table 4-1. There were no significant differences in the baseline
characteristics of participants between groups.

4.5.2

Compliance to energy restriction

The energy-restriction compliance rates were 65.1% for the AED group and
67.4% for the NFD group at 12 weeks. There were no significant differences in
compliance to energy-restriction as assessed by the dietary intake data and weight loss
between the AED and NFD intervention groups at 12 weeks (P=0.82).

4.5.3

Compliance to intervention groups

Data from 24-hour recalls indicated that total energy, carbohydrate, fat, protein
and sodium intake decreased over time (P<0.05). The percentage of energy from fat and
total MUFA, oleic acid, MUFA/SFA ratio, linoleic acid, total alpha-tocopherol,
magnesium, copper and phytic acid intake (almonds are rich in these nutrients) was
greater and percentage of energy from carbohydrate lower in the AED group compared to
the NFD group at the end of the intervention (P<0.05) (Table 4-2).
The shotgun metabolomics analysis conducted on 61 participants whose
erythrocytes were collected indicated that specific ratios and combinations of mainly
membrane lipids such as phosphatidylcholine and sphingomyelin were discriminatory of
almond consumption from the nut-free diet at the end of the 12 week intervention in the
AED group (J Dhillon, CR Ferreira, TJP Sobreira, unpublished data). However, 8
participants in the AED group and 3 participants from the NFD group were misclassified
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into the opposite group indicating possible non-compliance to their respective
interventions which was supported by dietary intake data. These participants, as well as
those not compliant to the energy restriction, were excluded from the secondary
compliers analysis. There were no significant differences in overall compliance based on
weight loss and metabolomics analysis to the AED and NFD intervention groups at 12
weeks (P=0.51). The baseline characteristics of the compliers are shown in Table 4-1.

4.5.4

Anthropometric outcomes

Body weight significantly decreased after the intervention in both analyses
(P<0.05).There was no difference in weight loss between the AED and NFD groups in
both the intention-to treat and compliers analyses (Table 4-3).
Trunk and total fat mass and percentage significantly decreased after the
intervention (P<0.05) in both analyses while trunk and total fat-free mass significantly
decreased only in the compliers analysis and trunk and total fat-free mass percentage
significantly increased after the intervention in both analyses (P<0.05) (Figure 4-2). The
compliers analysis indicated a significantly greater decrease in trunk fat mass and
percentage and total fat percentage and a significantly greater increase in the trunk and
total fat-free mass percentage in the AED group compared to the NFD group (P<0.05)
(Figure 4-2).
SAD and waist circumference significantly decreased after the intervention in
both analyses (P<0.05). No significant differences were observed between the AED and
NFD groups after the intervention in both analyses (Table 4-3).
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VAT predicted using both models significantly decreased after the intervention
(P<0.05) in both analyses (Table 4-3). Although there was a trend for greater VAT loss in
the AED group compared to the NFD group (Model 1: P=0.097) in the compliers
analysis, this difference was not statistically significant (Table 4-3). Even though VAT
model 2 was validated only for women, it strongly correlated with VAT model 1 for both
men (r=0.941, P<0.0001) and women (r=0.923, P<0.0001) (Baseline correlations shown).
Resting systolic blood pressure significantly decreased after the intervention
(P<0.05) while resting diastolic blood pressure remained unchanged for all participants.
However, resting diastolic blood pressure significantly decreased in the AED group after
the intervention (P<0.05) but not in the NFD group for participants compliant to the
intervention (Table 4-3). Twenty-four hour ambulatory systolic and diastolic blood
pressures remained unchanged at the end of the intervention in both analyses. In general,
ambulatory blood pressure readings were significantly higher during waking hours i.e.
from 8 am to 11 pm (systolic: 123.5 ± 0.6 mmHg, diastolic: 73.9 ± 0.46 mmHg)
compared to sleeping hours i.e. 11 pm to 8 am (systolic: 113.5 ± 1.04 mmHg, diastolic:
64.08 ± 0.94 mmHg) (P<0.05).

4.5.5

Serum lipids, insulin and glucose

Fasting serum insulin, triglycerides, total cholesterol, HDL and LDL cholesterol
remained unchanged after the intervention while fasting glucose increased significantly
after the intervention regardless of intervention group (P<0.05) (Table 4-3). In the
compliers analysis, fasting glucose remained unchanged after the intervention in both
groups (Table 4-3).
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4.5.6

24-hour free living appetite ratings

Twenty-four hour hunger, desire to eat and prospective consumption ratings
significantly decreased at the end of the intervention (P<0.05) with no difference between
the AED and NFD groups (Table 4-3). Fullness ratings remained unchanged at the end of
the intervention (Table 4-3). In the compliers analysis, hunger, desire to eat and fullness
ratings followed the same trend as in the intention-to-treat analysis but prospective
consumption ratings remained unchanged at the end of the intervention (Table 4-3).

4.5.7

Almond palatability and acceptance

The almond palatability ratings significantly decreased after the intervention (4.81 ± 2.2, (FACT scale units) P<0.05) while the almond acceptance ratings remained
unchanged (-0.29 ± 0.28, (gLMS units) P =0.308) for participants in the AED group in
the intention-to-treat analysis. The compliers analysis indicated no change in almond
palatability ratings after the intervention (-3.8 ± 2.8, P =0.194) and the almond
acceptance ratings remained unchanged as well (-0.16 ± 0.33, P=0.632).

4.5.8

Activity energy expenditure

Average activity energy expenditure was significantly higher on weekdays (0.7 ±
0.04 kcal/minute) compared to weekend days (0.59 ± 0.05 kcal/minute, P<0.05) but
remained unchanged over the intervention in both AED and NFD groups.
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4.6

Discussion

The present study had several important findings. Despite similar weight loss with
the two diets, almond consumption was associated with significantly greater proportional
improvements in overall body composition and greater fat loss in the trunk area in
compliant participants. Estimates of trunk fat (DEXA) are typically strongly correlated
with abdominal visceral fat (r=0.86-0.89) (31), hence a reduction in trunk fat could
reduce metabolic disease risk. One possible explanation for the greater fat loss with
almond consumption stems from their high unsaturated fat content. Unsaturated fats have
high fat oxidation rates which can preferentially reduce visceral fat (7).
Although we did not see a statistically significant difference in VAT loss between
the two diets, there was trend for greater reduction in VAT with almond consumption
when assessed using models that took into account DEXA estimates of trunk fat and
other measures of central obesity such as SAD and waist circumference. To our
knowledge two nut-based interventional trials have examined VAT directly and found
conflicting results (32,33). While one trial in overweight diabetic individuals observed
that walnut consumption led to significant reductions of fat in both visceral and
subcutaneous depots (33), the other trial in individuals with metabolic syndrome found
no reduction in visceral or subcutaneous adipose tissue (assessed by MRI) with pistachio
consumption for 24 weeks (32). Although the walnut trial was conducted in the context
of weight maintenance, participants still lost weight. Hence, nut consumption in the
context of weight loss might have greater effects on VAT loss. Nut-specific effects are
also possible though for most clinical outcomes and similarities are generally greater than
differences between nut types.
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Our intervention demonstrated a decrease in resting systolic BP in both groups,
but only the almond-enriched diet was associated with a reduction in resting diastolic BP
(-3.6%) in compliant participants. Our findings are in contrast to the preponderance of
clinical evidence that suggests no effect of tree nuts on resting BP in individuals without
prevalent CVD (34). Similar reductions in diastolic BP have been observed with peanut
consumption but only in individuals with elevated BP at baseline (20). Moreover, in the
PREDIMED trial, consumption of a nut-based Mediterranean diet for one year led to a
decrease in 24-hour ambulatory systolic and diastolic BP but only in high CVD risk
individuals (35). It is possible our findings reflect the use of almonds under energyrestricted, weight loss conditions which could augment reductions of diastolic blood
pressure (36).
In the present study, serum insulin and glucose remained unchanged with almond
consumption for 12 weeks. Although nut consumption has positive effects on glycemic
control (37), the long term effects are typically more favorable in prediabetic (38), and
diabetic individuals (39) or those with metabolic syndrome (40). In addition, there were
no changes in serum triglycerides, total cholesterol, HDL and LDL cholesterol with
almond consumption. The participants in our study were healthy adults with overweight
and obesity with no other CVD risk factors and the preponderance of nut-based evidence
shows the greatest improvements in blood cholesterol in individuals with high LDL
cholesterol and those with low BMI, and improvements in triglycerides in individuals
with hypertriglyceridemia (41). Moreover, these improvements were observed with an
average daily nut consumption of 67g whereas the participants in our study consumed
only 38g of nuts on an average.
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The satiating effects of almond consumption in acute feeding trials are well
documented (7). These properties have important implications for weight management as
they can translate into strong dietary compensatory responses. Whether these satiating
effects can be sustained chronically has yet to be established. In this 12-week clinical
weight loss trial, almond consumption reduced 24-hour hunger and desire to eat ratings to
a similar degree as the nut-free diet. But it is important to note that both intervention
groups underwent structured dietary counseling to make healthier and satiating food
choices.
Another consideration in long-term feeding studies is that of monotony effects
arising as a result of repeated daily consumption of specific foods (42). This is important
as it might undermine compliance to a dietary recommendation to increase consumption
of a given food. In our study, almond palatability ratings significantly decreased over
time but remained within acceptable range i.e. from over strongly palatable at baseline to
over moderately palatable at the end of the intervention. However, individuals compliant
to the intervention demonstrated no decline in almond palatability ratings (rated
consistently over strongly palatable) suggesting that these individuals may have been
more resistant to the monotony effects and hence more compliant.
In conclusion, incorporating modest quantities of almonds in a 12 week weightloss regimen led to significant reductions in weight and improvements in body
composition and blood pressure in healthy adults with overweight and obesity. The
clinical benefits of moderate almond consumption among individuals with or at a high
risk for metabolic syndrome and/or CVD have been repeatedly confirmed and the present
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findings indicate positive health effects among overweight, but otherwise healthy adults
as well.
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Table 4-1: Baseline characteristics of participants

Characteristic
Sex [n (%)]
Male
Female
Age (y)
BMI (kg/m2)
BMI Category [n
(%)]
Overweight
(BMI: 25-29.9
kg/m2)
Obese (BMI:
30-40 kg/m2)
Body weight (kg)
Waist
circumference
(cm)
SAD (cm)
Resting systolic
BP
Resting diastolic
BP
Total fat mass
(kg)
Trunk fat mass
(kg)
Total fat-free
mass (kg)
Trunk fat-free
mass (kg)
VAT (model 1)2
VAT (model 2)
Almond
palatability
ratings (gLMS)
Almond
acceptance
ratings (FACT
Scale)

Intention-to-treat (ITT) analysis
AlmondNut-free diet
enriched diet
(NFD) (n=43)
(AED) (n=43)

Compliers analysis
AlmondNut-free diet
enriched diet (NFD) (n=27)
(AED) (n=23)

11 (25.6)
32 (74.4)
31.05±12.91
29.91±3.2

10 (23.3)
33 (76.7)
31.77±13.15
30.97±4.48

8 (34.8)
15 (65.2)
33.57±12.86
30.33±3.22

7 (25.9)
20 (74.1)
34.93±13.11
30.56±3.87

23 (53.5)

21 (48.8)

10 (43.5)

13 (48.2)

20 (46.5)

22 (51.2)

13 (56.5)

14 (51.8)

82.79±12.9
88.05±8.69

84.71±14.12
90.23±9.80

83.46±12.94
90.09±8.69

82.22±14.59
90.21±9.38

21.91±2.65
123.11±11.39

22.24±3.09
121.12±8.62

22.63±2.81
124.67±9.25

22.41±3.01
121.19±8.15

75.22±8.79

73.85±7.15

74.52±6.45

76.32±9.63

31.67±7.49

33.09±8.93

31.63±8.56

32.04±8.67

16.14±4.53

16.96±5.42

16.63±4.81

16.71±5.16

50.08±9.62

50.60±8.81

50.82±9.78

49.26±9.63

22.47±4.41

22.84±3.72

22.82±4.54

22.34±3.87

92.42±43.95
100.96±32.29
68.26±1.85

106.62±51.01
107.14±40.12
-

104.59±45.14
109.95±33.18
72.46±2.17

114.83±42.69
110.54±38.59
-

6.86±0.17

-

7.102±0.19

-
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Mean ± SD (all such values), 2 ITT analysis-

 

 



analysis- AED: n=20, NFD: n=23. - Refers to not assessed. There were no statistically
significant differences in outcomes between the 2 intervention groups at baseline
assessed using independent-samples t tests.
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Table 4-2: Mean change in nutrient intakes over 10 weeks

Nutrients

Intervention groups
Almond-enriched diet
Nut-free diet
(AED) (n=43)
(NFD) (n=43)
-233.31±102.29
-292.28±105.09
-39.35±15.93
-23.05±16.37
-3.81±5.41
-19.02±5.56
-11.18±5.50
-9.02±5.64
1.40±1.55
0.59±1.59
-3.46±2.24
3.46±2.30
-1.20±1.22
1.04±1.26
3.67±1.88
-5.02±1.931
2.87±2.05
-8.16±2.101
4.06±.82
-2.52±.84
.47±1.76
-4.29±1.81
-6.39±2.27
-5.40±2.33
.77±.12
-0.03±.13
.31±.13
0.11±.14
3.26±1.95
-7.63±2.011
.79±1.61
-4.01±1.65
6.36±1.09
-1.72±1.12

Energy1 (kcal)
Carbohydrate1 (g)
Fat1 (g)
Protein1 (g)
Dietary Fiber (g)
% energy from carbohydrate2
% energy from protein
% energy from fat2
Total MUFA2 (g)
% energy from MUFA1,2 (g)
Total PUFA (g)
Total SFA1 (g)
MUFA/SFA ratio1,2
PUFA/SFA ratio1
Oleic acid2 (g)
Linoleic acid1,2 (g)
Total alpha-tocopherol1,2
(mg)
Magnesium2 (mg)
51.63±20.091
-14.89±20.65
2
Copper (mg)
0.13±.098
-0.24±.101
Phytic Acid2 (mg)
203.39±92.541
-74.97±95.07
1
Sodium (mg)
-400.29±269.87
-417.22±277.25
Values are mean ± SEM obtained from a linear mixed effects model with time as withinsubject factor and intervention group as between subject factor. 1 P<0.05 over 12 week
intervention, 2 P<0.05 AED vs. NFD
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Table 4-3: Mean change in outcomes over the 12 week intervention
Intention-to-treat (ITT)
analysis
AlmondNut-free diet
enriched diet
(NFD)
(AED) (n=43) (n=43)
-2.22±0.46
-1.09±.46
-4.31±1.48
-1.40±1.49

Characteristic

Compliers analysis
Almondenriched diet
(AED) (n=23)
-3.55±0.47
-8.19±1.81

Nut-free diet
(NFD) (n=27)

Body weight1 (kg)
-2.46±0.44
1,2
VAT (model 1)
-3.99±1.68
(cm2)
VAT (model 2)1
-9.04±1.31
-6.69±1.33
-12.82±1.60
-9.23±1.48
(cm2)
Waist
-4.36±1.78
-2.57±1.77
-3.24±0.44
-2.54±0.41
1
circumference (cm)
SAD1 (cm)
-0.797±0.15
-0.59±0.15
-1.15±0.18
-0.88±0.16
Resting BP (mmHg)
Systolic BP1
-3.11±1.35
-1.56±1.35
-3.23±1.85
-2.20±1.70
1,3
Diastolic BP
-1.07±0.92
0.07±0.92
-2.71±1.15
0.815±1.06
Fasting blood profile
(mg/dL)
Insulin
-1.17±2.32
-2.79±2.33
-3.54±3.81
-3.22±3.52
4
Glucose
3.20±1.80
2.57±1.81
2.61±2.63
4.41±2.43
Triglycerides
-18.10±11.43 -7.57±11.47 -17.65±18.70 -15.11±17.26
Total
-2.43±3.54
2.57±3.56
-1.61±4.5
2.26±4.15
cholesterol
HDL
2.65±1.40
0.57±1.41
1.99±2.03
1.69±1.87
LDL
-0.79±2.96
1.60±2.98
.212±4.14
1.22±3.82
Appetite ratings
(mm)
Hunger1
-3.15±2.61
-6.07±3.81
-3.42±3.54
-6.71±4.12
Fullness
0.09±2.89
1.88±4.19
0.25±3.97
1.89±4.60
Desire to eat1
-5.23±2.69
-5.63±3.93
-6.76±3.59
-4.87±4.19
Prospective
-3.45±2.47
-7.02±3.57
-3.29±3.41
-6.92±3.94
Consumption4
Values are mean ± SEM obtained from a linear mixed effects model with time as withinsubject factor and intervention group as between subject factor. 1 P<0.05 over time (12
week intervention) for both analyses, 2 ITT analysis- AED: n=36, NFD: n=37;



 

- AED: n=20, NFD: n=23, 3 P<0.05 AED vs. NFD, 4 P<0.05 over

time (12 week intervention) for ITT analysis only

91

Figure 4-1: Participant flow throughout the almond weight loss study.
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Figure 4-2: Mean change in total and trunk A) fat mass and B) fat-free mass C) fat mass
percent and D) fat-free mass percent over the 12 week weight loss intervention in the
AED and NFD groups.
Values are mean ± SEM obtained from a linear mixed effects model with time as withinsubject factor and intervention group as between subject factor. * P<0.05 over time (12
week intervention). ** P<0.05 AED vs. NFD groups. ITT analysis-AED: n=43, NFD:
 

    - AED: n=23, NFD: n=27. ITT: Intention-to-treat analysis.

AED: Almond-enriched energy restricted diet, NFD: Nut-free energy restricted diet.
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CHAPTER 5. EFFECTS OF ALMONDS ON COGNITIVE FUNCTION AND THE
POST LUNCH DIP IN ENERGY-RESTRICTED OVERWEIGHT AND OBESE
ADULTS

Dhillon, J., Tan S.Y. and Mattes R.D. Effects of almond consumption on the post-lunch
dip and short-term cognitive function in energy-restricted overweight and obese adults.
Br. J. Nutr (submitted on June 22, 2016)
The manuscript has been submitted to the British Journal of Nutrition and formatted
according to the requirements of the journal.

5.1

Abstract

The post-lunch dip in cognition is a well-established phenomenon of decreased
alertness, memory and vigilance after lunch consumption. Lunch composition reportedly
influences the post-lunch dip. Moreover, dieting is associated with cognitive function
impairments. The negative effects of dieting have been reversed with nut-supplemented
diets. The aims of this study were to 1) evaluate the acute effect of an almond-enriched
high fat lunch or high carbohydrate lunch on the post-lunch decline in cognitive function
and 2) evaluate the effects of chronic almond consumption as part of an energy-restricted
diet on the memory and attention domains of cognitive function. Eighty-six overweight
and obese adults were randomized to consume either an almond-enriched diet or a nutfree control diet over a 12-week weight loss intervention. The same participants were also
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randomized to receive either a high fat lunch (A-HFL) (>55% energy from fat, almonds
contributing 70-75% energy) or a high carbohydrate lunch (HCL) (>85% energy from
carbohydrates) at the beginning and end of the intervention. Memory and attention
performance indices such as concentration and qualitative performance decreased after
lunch consumption (P<0.05). The A-HFL group had smaller declines in memory scores
compared to the HCL group (P<0.05). Both lunch groups had similar declines in
attention. Hence, consumption of an almond-enriched lunch reduced the post-lunch dip in
memory. However, the macronutrient composition of the lunch did not affect the postlunch dip in attention. Moreover, memory and attention performance indices increased
after the intervention (P<0.05). But, there were no additional improvements in these
outcomes with almond supplementation.

5.2

Keywords

Cognitive function: Cognition: Post-lunch dip: Almonds: Nuts: Attention: Memory

5.3

Introduction

The post-lunch dip in cognitive performance is a well-established phenomenon of
decreased cognitive function in the early afternoon hours typically after lunch
consumption(1). It is thought to begin approximately one hour after the start of lunch
consumption. During the post-lunch dip, memory and vigilance are the most severely
affected domains, and decreased mood, alertness and anxiety are also reported(2,3). These
symptoms may negatively affect performance and increase personal and societal
risks(1,4,5). Lunch composition is reported to play a role in the post-lunch dip with high-fat
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lunches leading to slower(6,7) but more accurate(7) responses than low-fat lunches. Highcarbohydrate meals have a sedative effect promoting drowsiness in females and calmness
in males(8). Other studies have reported longer reaction times after consumption of
lunches higher in fat or carbohydrate than normal(9). There is heterogeneity to these
responses in terms of age. For example:   

 show impaired cognitive

performance after a high-carbohydrate lunch whereas adults < 40 years do not(8).
However, in healthy young adults, tasks that demand greater cognitive function are more
sensitive to nutrient manipulations(10). The unique nutrient profile of almonds, which is
lower in carbohydrate and high in protein and unsaturated fats, may lessen this post-lunch
dip in young and middle aged adults. If almonds are able to ameliorate the post-lunch dip,
they can enhance productivity (e.g., accuracy of written tasks) and safety (staying awake
while driving or working with machines).
Nut consumption over the long-term is also positively associated with cognitive
performance. In a five year prospective cohort study, the difference in cognitive
performance between the lowest and highest consumers of nuts was equivalent to a 5 to 8
year lesser age-related difference in cognitive function(11). In addition, individuals that ate
the most nuts had no cognitive decline over the 5 year study period (amount and types of
nuts unspecified)(11). In the PREDIMED study, walnut consumption was associated with
increased working memory in adults aged 55-80 years(12)

       



Study revealed higher long-term nut intake was associated with better cognitive
outcomes(13). In addition, women who consumed more than 5 servings of nuts per week
had higher global cognition scores than non-consumers; the difference in scores was
equivalent to the difference found in women aged 2 years apart. There is very limited
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data from interventional trials in humans to establish causation. In one trial, consumption
of brazil nuts (one nut per day) for 6 months improved verbal fluency and constructional
praxis in older adults with mild cognitive impairment(14). The only interventional study to
date conducted in young adults observed an 11% increase in inferential verbal reasoning
after consumption of 60g walnuts/day for 8 weeks(15). They observed no changes in nonverbal reasoning and memory scores.
The process of dieting to lose weight is associated with cognitive function
impairments(16) that could be a result of food restriction, anxiety related to maintaining a
weight loss regimen or preoccupying thoughts of hunger and desire to eat(17) and body
esteem(18,19). Negative effects of dieting on cognitive performance have been reversed
with nut-supplemented diets higher in fat and lower in carbohydrate(20). Hence, learning
and memory may also be enhanced with the inclusion of almonds during weight loss.
The beneficial effects of nuts on cognitive performance in the long-term are likely
due to the improvements in cardiovascular risk factors such as lipid profile, arterial
compliance, glucoregulation, oxidative stress, blood pressure and inflammation, with
subsequent improvements in endothelial function and cerebral vascular function(21). Nutrich Mediterranean diets reportedly increase brain-derived neurotrophin (BDNF)
concentrations in people with depression(22). High concentrations of BDNF are associated
with retention of memory and reduced cognitive decline(23

25)

. Nuts are high in

neuroprotective compounds such as Vitamin E, folate, melatonin, alpha linoleic acid
(ALA) (walnuts) and polyphenols(25). Although most tree and ground nuts generally have
similar nutrient profiles, some nut specific properties are purported to play a role in
maintaining cognitive functions and preventing cognitive decline. For example, walnuts
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have been widely studied in animal models(26,27) and in vitro(25), possibly because of their
previously established anti-oxidative and anti-inflammatory effects. The effects of
almonds on improving memory(28) in rats have been associated with their cholinergic,
anti-cholinesterase and cholesterol lowering properties(25,28).
The purpose of this study was two-fold. The first aim was to determine the postlunch changes in cognitive function with almond consumption at lunch compared to a
high-carbohydrate control lunch. We hypothesized that inclusion of almonds in a midday
meal will ameliorate the post-lunch decline in memory and attention compared to a high
carbohydrate control meal by lowering the percentage of dietary energy from
carbohydrates and increasing the percentage of energy from fat. The second aim was to
evaluate the effects of almond consumption as part of an energy-restricted diet on
cognitive function compared to a nut-free diet matched on energy-restriction (control).
We hypothesized that inclusion of almonds in an energy-restricted diet will improve the
attention and memory domains of cognitive function compared to the control.

5.4
5.4.1

Methods
Participants

Eighty-six healthy overweight or obese adults (21 men and 65 women)
participating in an almond weight-loss clinical trial were recruited. Eligibility criteria was
as follows: age of 18 60 years, BMI of 25-40 kg/m2, no nut allergies, willingness to
consume study foods and comply with the study protocol, no endocrine or metabolic
disorders, non-smokers and consistent diet and activity patterns. This study was
conducted according to the guidelines codified in the Declaration of Helsinki and is

98
registered on ClinicalTrials.gov (registration number: NCT02360787). All procedures
involving human subjects were approved by the Purdue Institutional Review Board.
Participants were recruited via public advertisements. Those meeting the eligibility
criteria were contacted to schedule a screening visit. Participants provided written
consent at the beginning of the screening session and were compensated for their time in
the study.

5.4.2

Intervention

The study was a 12-week randomized, controlled, parallel-arm weight loss trial.
In brief, participants were randomized into one of two energy-restricted study arms:
Almond enriched diet (AED) or nut-free diet (NFD) groups. Both groups received dietary
counseling to reduce energy intake to achieve 2092 kJ/day (500 kcal/day) deficits to
support weight loss. Weekly energy and nutrient analyses using 24-hour food recalls
were conducted to determine the part   





 



recommendations.
Forty-three participants were randomized into each of the AED and NFD groups.
Participants in the AED group were asked to consume dry-roasted, lightly salted almonds
providing 15% of the energy in their individualized energy-restricted diet. Energy from
almonds was accounted for during dietary modeling so that a 2092 kJ/day (500 kcal/day)
deficit was achieved. Participants in the NFD group were asked to avoid all nuts and nut
products during the intervention period. Cognitive function outcomes were assessed at
the beginning (baseline) and end of the 12-week intervention.
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5.4.3

Test meals for post-lunch dip assessment

Participants were randomized into either an almond-enriched high fat lunch group
(A-HFL), or a high-carbohydrate lunch group (HCL) at the beginning of the study. Lunch
provided 23-               

  

    

energy intake at lunch was determined from the What we eat in America, NHANES
2011-2012 survey that reports the percentage of energy intake at lunch according to sex
and age(29). Participants in the HCL meal were fed a combination of spaghetti in tomato
sauce (SpaghettiOs, Campbell, USA), white bread, jelly and apple juice providing greater
than 85% energy from carbohydrate. Participants in the A-HFL meal were fed almonds
with some Spaghetti Os and/or white bread, jelly and apple juice providing greater than
55% energy from fat. The almonds provided 70-75% energy in the A-HFL meal. An
example of a sample lunch is provided in Table 5-1. Participants were instructed to eat
the entire test meal. Cognitive function outcomes were assessed immediately after lunch
and 30-35 minutes later. In addition, the post-lunch dip assessments were performed at
baseline and at the end of the 12-week intervention.

5.4.4

Cognitive function test protocol

The cognitive function test protocol is shown in Figure 5-1. Participants arrived
in the laboratory in a fasted state for measurement of other variables pertaining to the
almond weight loss study such as body weight, body fat, blood pressure, serum insulin
and glucose etc. (reported elsewhere). Instead of assessing cognitive outcomes before
lunch in the fasted state, we assessed cognitive performance immediately after lunch in
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lieu of the pre-lunch time point as there is some evidence that breakfast skipping is
associated with negative cognitive consequences(30).
After measurement of the aforementioned variables, participants were provided
with a midday meal according to their randomized lunch group (A-HFD or HCL). They
were given 15 minutes to eat their meal after which they were taken into a quiet room for
cognitive function testing. Testing included memory and attention domains of cognitive
function. The tests for memory: immediate memory, delayed memory and verbal list
recognition tests were adapted from the repeated battery for the assessment of
neuropsychological status (RBANS) tests(31) w      

  



test of attention(32) respectively.
In the immediate memory test, participants were read a list of 10 words
immediately after lunch prior to the onset of the post-lunch dip. They were asked to
remember and recall the words after 2 minutes. The number of correct responses was
recorded. In the delayed memory test participants were asked to recall the same 10 words
read to them and record them on a sheet of paper 35 minutes after lunch consumption.
The number of correct responses was tallied.
In the attention test, participants were asked cross out the letter d accompanied
with 2 dashes (above the letter d, below the letter d or one dash above and one below the
letter d) on a recording blank with 14 lines of 47 letters comprised of either d or p with 1,
2, 3 or 4 dashes. They were given 4 minutes to do this task. The errors of omission
            iate targets) were
recorded. This test was used to assess quantitative performance (total number of items
processed, TN), qualitative performance (the total number of items processed minus total

101
errors, TNE) and concentration performance (the total number of correct items marked
minus errors of commission, CP). The attention tests were conducted immediately- and
30 minutes after lunch.
Finally, the verbal list recognition test

      

    

to recall the 10 words read out to them immediately after lunch. The tester read out a list
of 20 words and participants had to acknowledge verbally which words were present in
the initial list. The correct responses were marked.

               

 e used to fill in the 30

minute interval after lunch to ensure that participants did not fall asleep. Participants were
asked to cross out different combinations of irrelevant letters with dashes over 28
minutes. These tests were not graded.

5.4.5

Statistical analysis

A linear mixed model analysis was performed on the correct responses obtained

                     
attention (i.e., total number of items processed, concentration performance, quantitative
performance and qualitative performance. The intervention period (before vs. after) and
the lunch period (immediately after vs. 35 minutes after) were used as within-subject
factors and the intervention and lunch groups as between-subject factors. The correct
responses from the verbal list recognition test were analyzed using a linear mixed model
with intervention period as the within-subject factor and the intervention and lunch
groups as between-subject factors. An additional linear mixed model analysis on the
change in outcomes as opposed to absolute values was also performed. Age range, sex

102
and BMI range were also considered as between-subject factors for all the tests. When
significant interactions were observed, pairwise comparisons were carried out with
Bonferroni correction.
Between-group differences were assessed at baseline by using independentsamples t tests. Pearson statistics were used to determine correlations. The alpha level
was set at 0.05. SPSS (version 22, 2013, SPSS Inc.) was used for all the statistical
analyses. OriginPro (version b9.3.226, 2016, OriginPro Corporation) was used to graph
the data. Data are reported as means and standard errors (SEM). The sample size
calculations for this study were based on visceral fat which was one of the primary
outcomes for the almond weight loss study (reported elsewhere).

5.5
5.5.1

Results
Participants

The baseline characteristics of all participants are reported in Table 5-2. Of the 86
participants that were enrolled in the study, 7 withdrew during the intervention. Four
participants withdrew due to non-compliance with the dietary protocol, 1 withdrew due to
illness not related to the study, 1 female participant withdrew because of pregnancy and 1
withdrew due to lack of time to devote to the study. There were no significant differences
in attrition between the AED and NFD intervention groups at 12 weeks.

5.5.2

Compliance to intervention

Total energy intake decreased in both AED (-976.17±427.98 kJ) and NFD groups
(-1222.9±439.7 kJ) during the energy restriction period (P<0.05). The percentages of

103
energy from fat (36.62±1.42 vs. 29.36±1.46 (%, AED vs. NFD) and total MUFA
(27.70±1.43 vs. 15.43±1.47 g), total alpha-tocopherol (15.15±0.8 vs. 6.43±0.82 mg),
magnesium (311.98±16.85 vs. 245.36±17.31 mg), and phytic acid (850.86±64.13 vs.
614.42±65.89 mg) intake were greater and the percentage of energy from carbohydrate
(46.34±1.65 vs. 51.93±1.70 %) was lower in the AED group compared to the NFD group
at the end of the intervention (P<0.05). These nutrient intake patterns reflect the nature of
the dietary intervention.

5.5.3

Cognitive function outcomes

Memory outcomes
Memory scores did not differ between the A-HFL and HCL meals immediately
after lunch. However, memory scores decreased significantly 35 minutes after
consumption of lunch in both groups (P<0.05). The A-HFL meal was associated with a
significantly smaller decline in memory score 35 minutes after lunch consumption
compared to the HCL meal (P<0.05) (Figure 5-2).
In addition, there were no significant differences between the mean number of
correct words recorded immediately after lunch (immediate memory score) and mean
number of correct words recorded 35 minutes after lunch (delayed memory score)
between the AED and NFD groups at baseline. Both memory scores increased
significantly after the 12-week weight loss intervention period (P<0.05), but the
difference between the groups was not significant (Figure 5-3).
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Verbal list recognition (VLR) outcomes
There was no significant difference in the VLR score between the A-HFL and
HCL meals 35 minutes after lunch consumption. In addition, there was no significant
differences between the mean number of words correctly recognized verbally (VLR
score) between the AED and NFD groups at baseline. Although the VLR score increased
after the 12-week weight loss intervention in both groups (AED: 0.47±0.25, NFD:
0.63±0.25, no. of words, P<0.05), the difference between the groups was not significant.

Attention outcomes
The performance indices i.e. concentration performance (CP), quantitative
performance (TN) and qualitative performance (TNE) did not differ between the A-HFL
and HCL meals immediately after lunch. However, while CP and TNE decreased
significantly 35 minutes after consumption of lunch (P<0.05) (Figure 5-4), TN decreased
significantly 35 minutes after consumption of lunch only after the weight loss
intervention (Figure 5-4). There were no significant differences in the performance
indices between the AED and NFD groups at baseline. Although the performance indices
increased after the weight loss intervention (P<0.05), the difference between the groups
was not significantly different (Figure 5-5).
Participants aged 18-39 years had higher scores for all performance indices than
participants aged 50-60 years regardless of intervention group and post-lunch dip group
(P<0.05, data not shown). Age was also moderately correlated with all performance
indices regardless of group. The correlation coefficients between age and performance
indices (CP, TN and TNE) ranged from -0.348 to -0.487 (P<0.05)
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There was no effect of sex, weight category (BMI) or amount of weight loss on
memory, VLR or attention outcomes.

5.6

Discussion

The present study confirmed the presence of a post-lunch dip as evidenced by a
decline in the memory and attention performance domains of cognitive function 35
minutes after lunch consumption. An important finding of the study was the effect of
lunch composition on cognitive function. As hypothesized, the almond enriched high fat
lunch was followed by smaller declines in memory compared to the high carbohydrate
lunch. This acute effect of almond consumption may be attributable to their high fat and
fiber content and lower carbohydrate content. Almond consumption has previously been
shown to have a moderating effect on postprandial blood glucose concentrations(33,34). Fat
and fiber can lower postprandial glycemia by delaying gastric emptying(35) and intestinal
transit time(36) respectively. Lower than normal blood glucose concentrations impair
cognitive function(37). Hyperglycemia has also been associated with impaired
performance but primarily among individuals with diabetes(38). In one study, a low
glycemic index breakfast improved memory performance over a high glycemic index
breakfast indicating that the rate of glucose release into the circulation may be
responsible for these effects(39). Consumption of almonds with a meal can reduce the
glycemic impact of carbohydrate, thereby maintaining optimum blood glucose
concentrations for memory tasks.
Dietary factors other than lunch composition can influence the post lunch dip as
well. Some researchers believe that the midday meal size may influence the decline in
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cognitive function after lunch. Larger lunches are associated with an increased number of
errors in selective attention(40) and decreased cognitive performance in general(41)
compared to smaller lunches. In the present study, the amount of food given to
participants was based on 23-25% of their estimated daily energy requirements. This is in
line with customary intake levels in the population(29), so was ecologically valid though
perhaps not a test of the extent of the effect. Others argue that the post-lunch dip is more
attributable to endogenous rhythms(42) or is a consequence of conditioned lunch effects(43)
rather than being causally link to lunch composition or size. For example, some studies
have observed differences in cognitive function between late morning and early afternoon
   





  

(2,44)

but individuals who ate lunch had a

greater post-lunch dip in sustained attention compared to the lunch skippers(2). Although
we did not control the time at which lunch was provided to participants, there are limited
data indicating that the post-lunch dip in attention and reaction to a new stimulus is not
affected by the time at which lunch is eaten(2,44). Other causes of the post-lunch dip in
cognitive function have been proposed including insulin surges(45) increased cortisol (46),
or serotonin concentrations(8) among others.
In our study, almond consumption at lunch did not ameliorate the post-lunch dip
in attention. However, the attention domain of cognitive function may not be as sensitive
to macronutrient manipulation compared to the memory domain(47).
This twelve week randomized weight loss trial improved memory and attention
performance in overweight and obese energy restricted adults. This is contrary to what
has been observed in most(17,18,48) but not all(20) studies on dieting adults. The
improvement in cognitive function could stem from the intervention itself with
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participants having undergone dietary counseling to make healthier choices and lose
weight. However, in spite of restricting the testing occasions to before and after the 12
week intervention, there is a possibility of practice effects(49). There were no additional
improvements in memory and attention with almond supplementation. Although a
previous nut-based trial has demonstrated improvements in working memory and speed
of processing in energy restricted adults consuming nut-supplemented diets(20), this study
did not have a control group. Hence, a comparison of the magnitude of improvements in
cognitive function between a nut supplemented and a nut-free diet could not be made.
Although the present study showed no effects of BMI on cognitive function, a
recently published study observed a protective effect of obesity on cognitive function in
people aged 45 years and older, particularly in women(50). The lack of an effect noted
here may be attributable to the absence of normal weight individuals for comparison.
Interestingly, others have found a positive association between weight loss (over 12
years) and cognitive decline in older adults. While this is contrary to the improved effects
on cognitive function with weight loss observed in the present study, we did not
exclusively recruit older people and our intervention may not have been long enough to
observe these changes. We also did not find any BMI, age or gender interaction effects
on cognitive function. However, we did find a negative association between age and
 

    

        

 

decline with ageing is a common occurrence(51).
In conclusion, almond consumption acutely ameliorated the post-lunch dip in
memory and may be an effective means to maintain memory following the midday meal.
However, almond consumption over 12 weeks did not further enhance the improvements
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in cognitive function outcomes with weight loss. Nevertheless, literature indicates that
almond consumption enhances satiety(52) and reduces hunger and desire to eat(33),
properties that may minimize hunger-related thoughts that can acutely impair cognitive
function in dieters(17).
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Table 5-1: Nutrient composition of a sample lunch provided to a 28 year old male
participant on a 7431.2 kJ/day (1800 kcal/day) diet in both lunch groups

Food items*

Almond enriched high fat
lunch (A-HFL)
53g almonds (75% energy
of lunch)

      
1 cup water

High carbohydrate lunch
(HCL)

      

1 slice white bread (25g)
1 tbsp. jelly
½ cup apple juice
1 cup water
26

Energy (% daily
26
intake)
Carbohydrate (%) 31
86
Fat (%)
56
4
Protein (%)
13
10
* The study was not a crossover design, but this is exemplary of two meals for
participants with similar energy intake levels. 

   (29)
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Table 5-2: Baseline characteristics of participants

Age (y)
Body weight (kg)
BMI (kg/m2)

Intervention groups
Almond-enriched
Nut-free diet (NFD)
diet (AED) n=43
n=43
Mean SD
Mean
SD

Post-lunch dip experimental groups
Almond-enriched high
High carbohydrate
fat lunch (A-HFL) n=43 lunch (HCL) n=43
Mean
SD
Mean
SD

31.05 12.9
82.79 12.9
29.91 3.20

31.77
84.71
30.97

13.15
14.12
4.48

30.30
84.38
30.93

12.89
14.50
4.42

32.51
83.12
29.94

13.08
12.51
3.29

n

%

n

%

n

%

n

%

11
32

25.6
74.4

10
33

23.3
76.7

9
34

20.9
79.1

12
31

27.9
72.1

32
5
6

74.4
11.6
14.0

31
4
8

72.1
9.3
18.6

33
3
7

76.7
7.0
16.3

30
6
7

69.7
14.0
16.3

23

53.5

21

48.8

21

48.8

23

53.5

20

46.5

22

51.5

22

51.2

20

46.5

Sex
Male
Female
Age range
18-39 y
40-49 y
50-60 y
Weight Category
Overweight
(BMI: 25-29.9 kg/m2)
Obese
(BMI: 30-40 kg/m2)
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Figure 5-2: Mean change in memory scores immediately after lunch and 35 minutes after
lunch consumption in the almond enriched high fat lunch (A-HFL) and high carbohydrate
lunch (HCL) groups before and after the 12-week intervention.
Values are means and standard errors obtained from a linear mixed effects model with
lunch period and intervention period as within-subject factors and lunch group and
intervention group as between subject factors. * Significant differences for change in
memory scores over lunch period (P<0.05). ** Significantly different between the AHFL and HCL groups (P <0.05). A-HFL: n=43; HCL: n=43.Values are means and
standard errors. * Significant differences for change in memory scores over intervention
period (P<0.05). AED: n=43; NFD: n=43.
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Figure 5-3: Mean change in immediate and delayed memory scores before and after the
12-week intervention in the almond enriched diet (AED) and the nut-free diet (NFD)
groups.
Values are means and standard errors obtained from a linear mixed effects model with
intervention period and lunch period as within-subject factors and intervention group and
lunch group as between subject factors. * Significant differences for change in memory
scores over intervention period (P<0.05). AED: n=43; NFD: n=43.
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Figure 5-4: : Mean change in performance indices immediately after lunch and 35
minutes after lunch consumption in the almond enriched high fat lunch (A-HFL) and high
carbohydrate lunch (HCL) groups before and after the 12-week intervention.
Values are means and standard errors obtained from a linear mixed effects model with
lunch period and intervention period as within-subject factors and lunch group and
intervention group as between subject factors. * Significant differences for change in
performance indices over the lunch period (P<0.05). CP: concentration performance; TN:
quantitative performance; TNE: qualitative performance. A-HFL: n=43; HCL: n=43.

121

Figure 5-5: Mean change in performance indices before and after the 12-week
intervention in the almond enriched diet (AED) and the nut-free diet (NFD) groups
immediately after lunch and 35 minutes after lunch consumption.
Values are means and standard errors obtained from a linear mixed effects model with
intervention period and lunch period as within-subject factors and intervention group and
lunch group as between subject factors. * Significant differences for change in
performance indices over the intervention period (P<0.05). CP: concentration
performance; TN: quantitative performance; TNE: qualitative performance. AED: n=43;
NFD: n=43.
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CHAPTER 6. ASSESSING ALMOND CONSUMPTION COMPLIANCE BY FLOW
INJECTION METABOLOMICS

Dhillon, J., Tan S.Y. and Mattes R.D. A shotgun fingerprinting approach to document
compliance with an almond consumption intervention. Metabolomics (submitted on June
30, 2016)
The manuscript has been submitted to the Metabolomics journal and formatted according
to the requirements of the journal.

6.1

Abstract

Introduction: Almonds are extremely rich sources of lipids and flavonoids and their
consumption is associated with several health benefits. However, there are no known
analytical methods to document compliance to almond consumption in the long run.
Objective: To develop an analytical approach that identifies metabolic profiles
associated with long-term almond consumption to ascertain compliance with prescribed
consumption.
Methods: A shotgun fingerprinting strategy was designed to isolate metabolic changes
in erythrocytes after 12-wk almond consumption. Representative samples (pools) of
erythrocytes from individuals consuming almonds or no almonds were screened by flow
injection mass spectrometry. Data based on scan modes for shotgun lipidomics, and m/z
values compatible with almond flavonoid content were collected. Specific ion pairs and
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m/z values detected in pooled samples were combined into single ion monitoring and
multiple reaction monitoring methods intended for individual sample screening.
Results: Out of the 243 values of m/z monitored by both methods, 5 ratios and
combinations of specific ions with receiver operating characteristic (ROC) curves
AUC>0.89 had sensitivity of 74.2% and specificity of 90%. Eight out of the 31
participants (25.8%) in the almond group and 3 out of the 30 (10%) participants in the
control group were misclassified by all 5 ratios.
Conclusion: Ratios and combinations of specific ions mainly related to membrane lipids
were discriminatory of almond consumption from the nut-free diet. The
misclassifications observed as a result of ratio performance evaluation could be
indications of possible non-compliance as supported by the dietary intake data.

6.2

Keywords

Almond Biomarkers; Human Erythrocytes; Metabolomics; Nuts; Shotgun Lipidomics

6.3

Introduction

Almond consumption is associated with several health benefits such as
improvements in lipid profile, glycemic control and vascular health (Barbour et al. 2014;
Kendall et al. 2010). In addition, despite their high energy content, almond consumption
does not promote weight gain (Flores-Mateo et al. 2013) and recent evidence indicates
that almonds may improve body composition (Hollis and Mattes 2007). Almonds are
good sources of monounsaturated fatty acids (MUFAs), protein, fiber, arginine, vitamin
E, polyphenols and magnesium. These nutrients have been implicated in the

124
aforementioned health benefits (Kendall et al. 2010) but characterization of their benefits
requires additional clinical study.
Assessing compliance to dietary interventions in long-term clinical trials is
frequently problematic. Although self-reported measures of intake such as 24-hour food
recalls and food frequency questionnaires are widely used, these are subjective measures
of dietary intake (Johnson 2002) and only capture an imperfect snapshot of an
individual s dietary pattern. Compliance to long-term almond consumption is
occasionally documented using plasma alpha-tocopherol (Hollis and Mattes 2007; Li et
al. 2011). However, plasma alpha-tocopherol is more strongly associated with vitamin E
supplement intake (Ascherio et al. 1992; Stryker et al. 1988) and might not reflect intake
of vitamin E from dietary sources such as nuts (Kardinaal et al. 1995). Hence, there is a
need to develop methods that can identify metabolic profiles associated with long-term
almond consumption in order to ascertain compliance to an almond consumption
prescription.
Nutritional metabolomics is a relatively new domain of nutrition that can capture
the phenotype of dietary exposure in biological samples (Scalbert et al. 2014). Although
urine and blood plasma samples are commonly used in the application of nutritional
metabolomics, red blood cells (erythrocytes) may reflect longer-term dietary intake
(Catalán et al. 2013) since the average erythrocyte lifespan is between 70 to 140 days
(Franco 2012). Because almonds are a rich source of lipids, it is reasonable to screen for
diverse lipids in the erythrocytes of individuals chronically consuming almonds.
Flow injection mass spectrometry (FIA-MS) is a simple, fast and informative
mass spectrometry strategy for the targeted or untargeted screening of lipids and
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metabolites that can be used for this purpose. It is based on the direct injection (without
chromatographic separation) of crude lipid extracts on electrospray (ESI) ion sources.
Targeted analysis by FIA-MS can be performed by screening for values of m/z or ion
pairs related to specific metabolites or lipids. Untargeted analysis by FIA-MS can be
performed by full mass scan or by shotgun lipidomics. Shotgun lipidomics takes
advantage of neutral loss (NL) and precursor ion (PREC) scan mode experiments to
profile diverse classes of lipids based on the fact that the lipid chemical structure is
    

    

      

fragment ions (detected by PREC experiments) or losses (detected by NL
experiments)(Han and Gross 2005). However, because of ionization suppression,
isotopic, isobaric and isomeric interferences likely occur during flow injection and may
impair quantification accuracy, we did not quantify the lipids but rather used relative
amounts of lipids and named this approach shotgun fingerprinting. This approach
simplifies identification of relevant lipids by avoiding the necessity of internal standards,
chromatographic separation and, by simplifying data and metabolite structural analysis,
workflow.
The objective of the present study was to apply shotgun fingerprinting to assess
compliance to almond consumption by screening for prospective biomarkers in
erythrocytes that were discriminatory between individuals that consumed almonds and
those that did not consume any nuts. In addition, because almonds also contain
substantial amounts of flavonoids (Bolling et al. 2011), we screened the literature for
flavonoids identified in almond skins (Bolling et al. 2009) and included them in the
method for individual sample screening. Screening of the selected values of m/z, which
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were related to lipids and metabolites in erythrocytes, indicated the presence of 19
molecule ratios highly discriminatory between individuals that consumed almonds and
those that did not consume any nuts. Out of the 19 ratios, 5 were explored in more detail.
The 10 m/z values present in the five selected ratios have been further analyzed by full
MS/MS to obtain some structural identification. The results suggest that long term
almond consumption impacts erythrocyte cell membrane composition. This information
can be useful for assessing compliance to long-term almond consumption. Nonetheless, it
is important to consider that the identified informative ion combinations related to lipids
are only prospective biomarkers. Detailed structural identification (presence of isobars
and isomers, location of unsaturation in the fatty acyl residues) and absolute
quantification by LC-MS/MS and/or high mass resolution will come at later stages.
Biomarker validation was not in the scope of this study.

6.4
6.4.1

Methods
Participants

Sixty-one healthy male and female overweight or obese individuals (age: 18 60
and BMI: 25-40 kg/m2) participating in an almond weight loss study (ClinicalTrials.gov
(registration number: NCT02360787)) were recruited.

6.4.2

Intervention

The study was a randomized, controlled, parallel-arm, 12-week, clinical trial.
Participants were randomized into one of two 500 kcal energy-restricted study arms:
Almond enriched diet or nut-free diet groups (Table 6-1). Weekly energy and nutrient
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analyses using 24-hour food recalls were conducted to determine the pa



compliance to dietary recommendations. Participants randomized into the almondenriched energy restricted diet group (n=31) were asked to consume dry-roasted, lightly
salted almonds providing 15% energy in their individualized energy-restricted diet.
Participants randomized into the nut-free energy restricted diet group (n=30) were asked
to avoid all nuts, seeds and nut products during the intervention period.

6.4.3

Sample extraction and shotgun fingerprinting data acquisition

Fasting blood samples (5 ml) were collected from participants at baseline and the end of
the 12 week intervention into vacutainers with EDTA. The erythrocytes were separated
from the plasma by centrifugation and frozen at -80ºC. The erythrocytes were prepared
by hemolyzing the cells two times in deionized distilled water followed by centrifugation
at 4000 RPM for 10 minutes at 4ºC (Allegra 25R centrifuge; Beckman Coulter, Brea,
           

   

The lipid extracts were prepared using a procedure by Rose and Oklander (Rose
and Oklander 1965). Erythrocytes (150uL) were mixed with 150uL of ultrapure water
and the contents were allowed to stand for 15 min with occasional mixing (vortex).
Isopropanol (1.0 mL) was added to the mixture with occasional mixing. After 30 minutes,
600uL of chloroform was added, mixed and allowed to stand for another 30 minutes. The
tube was centrifuged at 10,000xg for 10min (Taylor Scientific Centrifuge). The lipid
extract (bottom phase) was subsequently removed and transferred to another tube and the
solvents were removed by evaporation in a Speed Vac concentrator. Dried Lipid extracts
were resuspended in 270uL of acetonitrile (ACN)/methanol/ammonium acetate (300mM)
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at 3:6.65:0.35 volume ratios. The solvent pumped by the microsampler between
injections was ACN + 0.1% formic acid.
The lipid extract from almond seeds was prepared using a procedure by Bligh and
Dyer (Bligh and Dyer 1959) for comparison purposes. Four almond seeds were
individually homogenized in 1 mL of water using a Precellys®24 tissue homogeneizer
(Bertin Technologies, Rockvielle, MD, USA). The homogenate (800 uL) was transferred
to a 15mL Falcon tube and mixed with 1 mL of chloroform and 1.6 mL of MeOH. After
mixing and 15 min incubation at room temperature, 1 mL of chloroform and 1 mL of
water were added, causing the formation of a 2-phase solution. The lipid extract (bottom
phase) was subsequently removed and dried under N2 stream. Aliquots of the four
almond seeds were then combined for further experiments.
Lipid extracts (6 µL) from individual participants and the almond seeds were
delivered using FIA-MS to a triple quadrupole mass spectrometer (Agilent QQQ 6460)
equipped with a jet stream ESI ion source. The lipid extracts from participants were
pooled into 3 groups for running the diverse scan modes and finding the lipids detectable
in the samples. The first group comprised of lipid extracts of all participants at baseline
(n=52) regardless of intervention group (Baseline), the second group comprised of lipid
extracts of participants that consumed almonds at the end of the intervention (W12almonds, N=30), and the third group comprised of lipid extracts of participants that did
not consume any nuts or nut products at the end of the intervention (W12-control; N=31).
These classifications were made based on the information obtained from the scans run on
a selected few known compliant participants.
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Full scan at the positive and negative ion modes and over 80 scan modes were run
on the lipid extracts from the 3 pooled samples and almond seeds (data not shown);
nonetheless, only 20 scans were informative, i.e. presented ions (Table 6-2). Initial data
processing of the profiles obtained was carried out by MassHunter (B.06.00). The most
informative ions identified through the scans on the pooled samples and the almond seeds
were organized into two methods (one for the positive and another one for the negative
ion mode) for multiple reaction monitoring (MRM) or single ion monitoring (SIM). With
the inclusion of the m/z values related to anthocyanins, 243 values of m/z were monitored
in the 114 individual samples of the three experimental groups. It is important to consider
that some of the m/z values present in the shotgun lipidomics profiles and selected for
screening may be isotopic patterns and some may have more than one molecule (isobaric
and isomeric compounds). Therefore, structural identification of the m/z values was not
pursued until the relevant ones were isolated by univariate and multivariate analysis.
Also, we included in the MRM and SIM methods ions compatible with flavanoids present
in almonds and nuts (Bolling et al. 2009; Gu et al. 2003). In total, 243 SIM or MRMs
related to lipids and flavonoids were monitored in individual samples organized into two
methods i.e. positive ion mode

148 values of m/z, negative ion mode

106 values of

m/z.

6.4.4

Data analysis

For the informative shotgun fingerprinting scans (Table 6-2), the mass spectra had
the background subtracted and values of m/z were exported for organization into the two
screening methods. The files generated by the mass spectrometer were converted to
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mzML format using MSConvert (http://proteowizard.sourceforge.net), and an in-house
script was developed to sum the ion intensities from 0.4-1.0 min of data acquisition of
each of the 243 m/z values monitored. The values of ion intensities of each m/z were
normalized by total ion current (TIC) to obtain relative ion intensities. The dataset was
then filtered out to remove any ions that did not appear in over 50% of the samples. Data
were then auto scaled. The differences in the erythrocyte metabolome due to the diet
factors (W12-Almond versus W12-Control) and time of intervention factors (Baseline
versus W12) were analyzed via univariate (volcano plots) and multivariate (PCA)
statistics using Metaboanalyst 3.0 (Xia et al. 2015). The performance of the identified
metabolites in discriminating W12-Almond from W12-Control was evaluated by
constructing receiver operating characteristic curves (ROCs) on the dataset, and
estimating the area under the curve (AUC). The 50 most informative values of m/z i.e.
those discriminating between W12-Almond versus W12-Control with AUC>0.75 were
considered for computation of different combinations and ratios by hand and using the
ROC feature of Metaboanalyst. The ratios with AUC>0.89 were considered as
informative and submitted to PCA to visualize the difference between groups. The 50
informative values of m/z were also submitted for MS/MS analysis for lipid class and
unsaturation level attribution (data shown only for the values of m/z present in the 5
selected ratios; Figure 6-5).

6.5

Results and discussion

The overall goal of this research was to assess compliance to an almond
consumption protocol for weight loss using a novel concept of shotgun fingerprinting.
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This analytical strategy is shown to be informative, rapid and a high-throughput strategy
for erythrocyte metabolomic screening. The workflow utilized in the study (Figure 6-1)
was based on fast sample preparation of erythrocytes, lipid profiling via FIA-MS
including full scan, screening of flavanoids and multidimensional MS scans targeted at
specific functional groups of metabolite classes.
Multivariate analyses of shotgun fingerprinting by principle component analyses
(PCA) of all 243 ions showed no clear discrimination between the erythrocyte
metabolome of the two intervention groups at baseline which was expected (Figure 62A). In addition, we did not see a discrimination between the metabolomic profiles of the
two groups over time (Baseline vs. W12) (Figure 6-2A). This could be a result of an
absence of a diet standardization phase prior to the start of the intervention. Hence,
participants may have either been consuming nuts or abstaining from nut consumption
prior to the intervention and this could have confounded identifying differences over time
in each group. However, we did see a relatively distinct clustering of the almond and
control groups at the end of the intervention (Figure 6-2B). This may indicate that either
some participants were not complaint to their respective intervention groups or that the
metabolites were not the best biomarkers of almond consumption.
Nevertheless, we evaluated the performance of the most informative ions
indicated by ROC analysis (n=50, AUC>0.75) in discriminating between the almond and
the control groups at the end of the intervention. In addition, we evaluated the
performance of different combinations and ratios of all metabolites as relationships
between multiple metabolites can capture information lost in univariate and multivariate
methods and may provide more relevant information regarding a biological system than
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individual metabolites alone (Steuer 2006). Out of the 243 ions monitored, 9 were
observed in 19 ratios and/or combinations which presented ROC curves with AUC>0.89.
A PCA of the 19 ratios demonstrated a distinct clustering with very little overlap of the
almond and control groups at the end of the intervention (Figure 6-3). Out of the 19
ratios, 5 ratios that presented the most unique combinations of ions and those with the
most informative fold changes were selected (Table 6-3).
Structural information obtained from the MS/MS experiments of the m/z values
included in the 5 selected ratios is listed in Table 6-4. Most ions presented the fragment
of m/z 184 which is diagnostic of phosphatidylcholine (PC) and sphingomyelin (SM)
lipids. Also values of m/z coincident with flavonoids were included in the ratios.
However, MS/MS was not diagnostic for these ions (Table 6-4).
All 5 ratios had a sensitivity of 74.2% and specificity of 86.7% (Figure 6-4) i.e. 8
out of the 31 participants in the almond group and 3 out of the 30 participants in the
control group were misclassified indicating a possibility of non-compliance. To confirm
whether these participants were non-compliers in their respective intervention groups, we
evaluated their dietary intake data. Non-compliers in the almond group demonstrated a
trend for either reduction in or inconsistent intake of MUFA, arginine, vitamin E and
phytic acid (nutrients that are high in almonds) over the intervention period while noncompliers in the control group demonstrated a trend for either an increase in or
inconsistent intake of the aforementioned nutrients over the intervention period
(unpublished data). In contrast, participants that were categorized as compliers in the
almond group had greater MUFA, arginine and vitamin E intake over the intervention
(unpublished data). Although the extremely small number of possible non-compliers
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precluded a statistical determination of the dietary intake data, it is reasonable to assume
that based on shotgun fingerprinting and dietary intake data, they might not have been
complaint to their respective intervention groups.
However, additional studies to are still needed to validate compliance to almond
consumption in clinical trials using this approach. The concept of shotgun fingerprinting
is similar to full mass scan profiling/fingerprinting used in a number of studies for food
quality (Porcari et al. 2016; Saraiva et al. 2009; Sawaya et al. 2010) and proof of origin,
adulteration (de Souza et al. 2007; Haddad et al. 2008), developmental biology (Ferreira
et al. 2015), bacterial identification (Barreiro et al. 2012; Song et al. 2007) and disease
diagnosis (Alfaro et al. 2016; Wiseman et al. 2005). We propose the use of
multidimensional scans and a much simpler workflow compared to traditional
metabolomics for biomarker discovery based on liquid (LC) or gas chromatography
(GC), or capillary electrophoresis (CE). This analytical approach is mainly based on
shotgun lipidomics features that use relative amounts of data and biomarker-discovery
based statistic tools. The guiding principle of the method is the high-throughput
utilization of the unique chemical and physical properties of small molecules present in
the samples. Shotgun fingerprinting presents limitations for precise structural
identification of the prospective biomarker combinations proposed due to the lack of
chromatographic separation combined with frequent isomeric and isobaric nature of
lipids. Therefore, more than one lipid isomer or even lipid class of compounds may be
present at the same m/z and the molecular species. Even though we have acquired
MS/MS data of the most relevant ions described in the study (Figure 6-5), they should be
further evaluated as biomarkers in subsequent experiments including chromatographic
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separation, high mass resolution MS or even more sophisticated tools such as ion
mobility MS.

6.6

Conclusion

The exploration of the erythrocyte metabolome in 61 subjects (W12-Almond and
W12-Control samples) by shotgun fingerprinting identified ratios and combinations of
specific ions mainly related to membrane lipids which were discriminatory of almond
consumption from the nut-free diet at the end of the 12 week intervention. While we
cannot ascertain at this point whether the informative metabolites detected are biomarkers
of almond consumption, the relationship between different metabolites indicates almondinduced changes in the metabolomics profile and the misclassifications observed as a
result of the ratio performance evaluation could be indications of possible noncompliance as supported by the dietary intake data. Nevertheless, the repeatability and
validity of this method will have to be tested in future studies with larger datasets and
more certain control of dietary compliance.
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Table 6-1: Baseline characteristics of participants in the intervention
Characteristic
Sex [n (%)]
Male
Female
Age (y)
BMI (kg/m2)
a) Mean ± SD (all such values)

Almond-enriched diet
(n=31)

Nut-free diet
(n=30)

7 (22.6)
24 (77.4)
32.06±13.61a)
29.97±3.34

6 (20)
24 (80)
33.40±13.21
30.93±4.52
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Table 6-2: Informative scan modes for screening diverse lipid classes in the shotgun
lipidomics study
Scan mode
full scan negative
full scan positive
full scan
positive m/z
NL 141
NL 183

Ion detected
[M-H][M+H]+
and
[M+H]+
and
[M+H]+
[M+H]+

PREC 184

[M+H]+

PREC 255.2
PREC 264.3
PREC 266.4
PREC 279.2
PREC 281.2
PREC 282.2
PREC 283.2
PREC 303.2
PREC 305.2
PREC 327.3

[M-H][M+H]+
[M+H]+
[M-H][M-H][M+H]+
[M-H][M-H][M-H][M-H]-

PREC 329.3

[M-H]-

PREC 331.3

[M-H]-

[M+H]+
PREC 85
[M-H]PREC 97
NL, neutral loss; PREC, precursor ion

Targeted lipids/metabolites
Free fatty acids, cholesterol sulphate
Glycerolipids
Triacylglycerol (TAG)
Phosphatidylethanolamine (PE)
Phosphatidylcholine (PC), alkelnyl-acyl PC
(ePC), sphingomyelin (SM) and LysoPC
Phosphatidylcholine (PC), alkelnyl-acyl PC
(ePC), sphingomyelin (SM) and LysoPC
Glycerolipids containing Palmitic acid residue
Ceramides (d18:1; sphingosines)/cerebrosides
Ceramides (d18:0; sphinganines)
Glycerolipids containing linolenic acid residue
Glycerolipids containing oleic acid residue
Ceramides (t18:0 4-hydroxysphinganines)
Glycerolipids containing stearic acid residue
Glycerolipids containing arachidonic acid
Glycerolipids containing eicosatrienoic residue
Glycerolipids containing
docosahexaenoic (DHA) residue
Glycerolipids containing Eicosapentaenoic
acid (EPA) residue
Glycerolipids containing
docosatetraenoic acid residue
Acylcarnitines
Sulfatide (ST)
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Table 6-3: Fold change of the five selected m/z ratios and combinations between almond
diet group and nut-free diet group at the end of the 12 week intervention i.e. (W12almond/W12-control).
Selected m/z ratiosa)

Fold
log2(FC)
P-value
change
(447 X 930.5) / (703.5 X 988.5 X
2.5901
1.373
0.000000172
(447 X 930.5)/ (703.5 X 876.5)
4.7656
2.2527
0.00000546
(447 X 930.5 X 782.5)/ 703.5
8.5938
3.1033
0.0001237
(447 X 930.5 X 782.5)/ 813.5 -> 629.5
9.083
3.1832
0.00012746
(447 X 930.5)/ (703.5 X 814.5)
6.8211
2.77
0.0000514
a) Ion intensities have been measured by monitoring just the parent ion both in Q1 and
Q3, except for the m/z 813.5, which has had the fragment of m/z 629.5 monitored. Ion
modes of each ion or ion pair are displayed in Table 6-4.
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Table 6-4: Metabolites associated with almond consumption in the shotgun
fingerprinting of participants erythrocytes.
m/z
447
703.5

Ion
[M-H] [M+H] +

Attribution (MS/MS)
Not attributeda)
Sphingomyelin SM (d18:1/16:0)
or SM(d16:1/18:0)b)
930.5
[M]+NH+
TAG(56:3)c)
+
782.5
[M+H]
Phosphatidylcholine PC(36:4)b)
814.5
[M+H] +
PC(38:2)b)
813.5
[M+H] +
SM (d18:2/24:0) or SM(d18:1/24:1)
813.5 -> 629.5 [M+H] +
SM (d18:2/24:0) or SM(d18:1/24:1)
+
876.5
[M]+NH
Not attributedd)
+
988.5
[M]+NH
TAG (62:16)c)
1016.5
[M+H]+ or [M]+NH+
Not attributede)
a) Value of m/z expected for diverse flavonols (such as Kaempferol 3-O-glucoside and
Quercetin) but fragments expected were not found by MS/MS.
b) Attribution was based on presence of the fragment ion at m/z 184 corresponding to
the glycerolipid polar head (phosphocholine), which is present in the product ion
analysis of protonated choline-containing phospholipid molecular species such as
phosphatidylcholine (PC) and sphingomyelin (SM). Metlin database
(https://metlin.scripps.edu) was used to search attributions. See Figure 6-5 for MS/MS
spectra.
c) TAG  triacylglycerol. In parenthesis are the number of carbon in the TAG fatty acyl
residues and the number of unsaturations, separated by a colon. Tentative attribution
due to lack of specific fragments for TAG lipids
d) MS/MS spectrum with no fragments up to collision energy of 35. Values of m/z not
compatible with TAG.
e) Low intensity MS/MS spectrum, indicative of a dimer or adduct
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Figure 6-1: Shotgun fingerprinting study workflow for almond consumption compliance
Lipid extracts were injected without chromatographic separation into the ESI source (flow
injection) and data on full mass scan and on diverse shotgun lipidomics scan modes were
collected for each representative sample (pooled baseline, pooled W12-almond and pooled
W12-control samples). The ions observed and m/z values of flavonoids reported in
literature were organized into two methods including SIM or MRM. Since this workflow
is mostly based on multidimensional MS experiments to perform chemical profiling, we
refer to it as shotgun profiling
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Figure 6-2: PCA score plots of all 243 ions
(A) PCA score plot of all 243 ions at baseline and W12. Colors indicate the experimental
groups. Red dots are from the almond group before diet intervention (baseline); green
dots are from the control group at baseline; dark blue dots are from the almond group
after the 12 week intervention (W12-Almond); and light blue dots are from the control
group after the 12 week intervention (W12-Control). (B) PCA score plot of all 243
values of m/z for the W12-Control and W12-Almond groups. Red dots represent W12Almond group; and green dots the W12-Control samples. The circles are drawn for
visualization (not related to statistical significance) of the W12-almond and W12-control
clusters.
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Figure 6-3: PCA score plot of the 19 m/z value ratios presenting AUC>0.89
Colors indicate the experimental groups. Grey dots are from the almond group after the
12 week intervention (W12-Almond); and black dots are from the control group after the
12 week intervention (W12-Control).
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Figure 6-4: Performance analysis of selected m/z ratios using ROC univariate curves
Graphs for ratios 1 to 5 show the averages, ±SD and error for the values. Individual
samples of W12-Almond and W12-control are depicted as open and solid symbols,
respectively. Lines are the ROC threshold used to classify samples in one of the two
groups.
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Figure 6-5: MS/MS spectrum of informative m/z values in ratios
(A) MS/MS spectrum of m/z 447 from almond seed extract; (B) MS/MS spectrum of m/z
    

   (C) MS/MS spectrum of m/z     

extract; (D) MS/MS spectrum of m/z     

    

collision energy no fragment characteristic of polar head fragment or neutral were observed.
Therefore a tentative attribution as a TAG is proposed. (E) MS/MS spectrum of m/z 782.5
   

   (F)       ! "#     

lipid extract; (G)       ! "#     

   (H)
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MS/MS spectrum of m/z 988.5

 

    

 

of polar head fragment or neutral were observed. Therefore a tentative attribution as a TAG
is proposed. Note: W12-almond and W12-control were pooled for the acquisition of
MS/MS data from erythr
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CHAPTER 7. SUMMARY AND FUTURE RESEARCH DIRECTIONS

7.1

Summary

Nut consumption can aid weight management due to their strong satiating effects,
the inefficient absorption of their energy, and possibly by elevating energy expenditure
and fat oxidation (Chapter 2). In addition, nuts have beneficial effects on body
composition, cardiovascular health, and cognitive function (Chapter 3). The unique
nutrient profile of nuts can also modulate the post-lunch dip in cognitive function
(Chapter 3).
This dissertation focused on almond consumption with three overall primary
aims. The first was to evaluate the effects of almond consumption as part of an energyrestricted diet on weight, body composition specifically the visceral depots and blood
pressure compared to a nut-free energy restricted diet (Chapter 4). The second was to
evaluate the effects of almond consumption as part of an energy-restricted diet on the
memory and attention domains of cognitive function (Chapter 5). The third was to
evaluate the acute effects of almond consumption on the post-lunch dip in the memory
and attention domains of cognitive function (Chapter 5). This research also contributed to
the methods literature by developing an analytical approach to identify metabolic profiles
associated with almonds to ascertain compliance to almond consumption in long term
clinical trials.
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7.2

Major findings

This dissertation provides new evidence for the beneficial effects of almond
consumption on body composition and blood pressure in the context of energy restriction
as well as for the acute effects of almond consumption in ameliorating the post-lunch
decline in cognitive function. The major findings of all the studies are presented below.

7.2.1

The effects of almond consumption on weight-related clinical outcomes

Almond consumption during a 12 week weight loss regimen compared to a nutfree weight loss regimen resulted in:
o Greater proportional reductions in trunk and total body fat mass in
participants compliant to the intervention
o Greater proportional increases in trunk and total body fat-free mass in
participants compliant to the intervention
o Greater reductions in diastolic blood pressure in participants compliant to
the intervention
o Similar reductions in weight, visceral adipose tissue, anthropometric
measures of abdominal adiposity such as SAD and waist circumference,
and systolic blood pressure for all participants
o Similar reductions in twenty-four hour hunger and desire to eat ratings for
all participants
Both the almond-enriched and nut-free weight loss diets demonstrated no changes
in the following outcomes over the 12 week weight loss intervention
o Twenty-four hour fullness ratings.

156
o Twenty-four hour ambulatory systolic and diastolic blood pressure
o Fasting serum lipid profile i.e. HDL, LDL, total cholesterol, and
triglycerides
o Fasting serum insulin and glucose. Although there was a significant but
not clinically relevant increase in fasting glucose levels for all participants,
fasting glucose concentrations remained unchanged for participants
compliant to the intervention.
Almond palatability and acceptance ratings remained unchanged over the weight
loss intervention in participants compliant to the intervention.
Compliance rates to energy restriction were similar in the almond-enriched and
nut-free weight loss diets
Age, sex and BMI had no effects on the aforementioned outcomes.

7.2.2

The effects of almond consumption on cognitive function and the post-lunch dip
in cognitive function
Both the almond enriched diet and nut-free weight loss diets resulted in similar
improvements in the memory and attention indices of cognitive function for all
participants after 12 weeks.
In the post-lunch dip analysis, consumption of an almond enriched high fat lunch
compared to the high carbohydrate lunch resulted in:
o Amelioration of the post-lunch decline in the memory domain of cognitive
function
o Similar post-lunch decline in the attention domain of cognitive function

157
Age of participants was negatively correlated with attention performance indices
of cognitive function
Gender, BMI and amount of weight lost had no effect on the cognitive function
outcomes over the 12 week intervention as well as in the post-lunch dip analysis.

7.2.3

The assessment of almond consumption compliance using an untargeted
metabolomics approach

Specific ratios and combinations of mainly membrane lipids such as
phosphatidylcholine and sphingomyelin were discriminatory of the almondenriched diet from the nut-free diet at the end of the 12 week intervention.
The relationship between these metabolites indicates almond-induced changes in
the metabolomics profile.
The misclassifications, 25.8% in the almond group and 10% in the nut-free group
observed as a result of the ratio performance evaluation could be indications of
possible non-compliance as supported by dietary intake data.

7.3

Future research directions

Would almond consumption elicit greater visceral fat loss in individuals with
greater obesity?
o Very few studies have directly assessed the effects of nut consumption on
visceral fat and have found inconsistent results(13). However, none of
these studies exclusively recruited obese individuals. Although visceral
adiposity varies greatly at a given BMI value (4), it is strongly correlated
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with total body fat and hence is expected to be higher in obese individuals
than overweight individuals. Although this dissertation research showed a
trend for greater visceral fat loss with almond consumption (Chapter 3), it
was not powered to detect a difference between overweight and obese
individuals. Therefore, additional research is needed to establish if almond
consumption in the context of energy restriction can result in significant
visceral fat loss in obese individuals.

Would the effects of almonds on blood pressure be more pronounced in
individuals at high CVD risk?
o The participants in this dissertation research were overweight or obese
with no other CVD risk factors. The majority of research demonstrates no
effects of nut consumption on blood pressure in individuals without
elevated CVD risk(5). Despite recruiting only low CVD risk individuals we
observed a greater reduction in diastolic blood pressure with almond
consumption compared to the nut-free diet (Chapter 3). However, the
health impact of almond consumption may be greater among individuals at
high CVD risk and needs to be investigated further.

Can almond consumption in long-term clinical trials result in monotony effects?
o Past research on almond influences on ingestive behavior has largely
focused on the presumed hormonal regulation (ghrelin, CCK, PYY, etc.)
of appetite and energy intake. However, the predictive power of these
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hormones, measured in the circulation, for appetite and intake is weak(6).
This may be due to a dominating effect of the reward system over the
appetitive system and poor correlation between circulating and brain
hormone concentrations(7). Emerging technologies, such as neuroimaging,
allow for a more direct assessment of brain activity in appetitive and
reward centers. Data from these studies indicate that increased activity
elicited by visual food stimuli in the mesolimbic dopamine system and
related brain structures is associated with increased appetitive drive and
motivated behavior(8,9). Documentation of almond effects on brain reward
centers would add considerable strength to the evidence that they are
palatable yet satiating and resistant to monotony effects, a combination
ideal for weight management.

What approaches may be implemented to identify and validate the biomarkers of
almond consumption?
o The metabolomics study presented in Chapter 6 raises important questions
concerning the unattributed metabolites that were discriminatory between
the almond enriched diet and the nut-free diet at the end of the
intervention. Those metabolites could be by products of microbial
degradation of flavonols as described by Urpi-Sarda et al(10). However,
that study assessed the metabolomic profiles of phenolic metabolites in
plasma and urine samples after consumption of almond skin polyphenols
in only two individuals. While that study was different from ours in
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several respects, including study design, biological samples (we used
erythrocytes), and metabolites screened, it provides some insight into the
identity of the unattributed metabolites. Nevertheless, there is a need for
detailed structural identification and absolute quantification by LCMS/MS and/or high mass resolution for biomarker validation which can
be explored in future studies.

Does almond consumption at lunch ameliorate the post-lunch decline in cognitive
function by moderating glycemia?
o This dissertation research showed that almond consumption at lunch
reduced the post-lunch decline in cognitive function (Chapter 5) but the
underlying mechanisms are unknown. Lower and higher than normal
concentrations of plasma glucose are known to impair cognition(11).
Almonds moderate postprandial blood glucose concentrations(12,13). There
is also evidence to suggest that low glycemic index meals improve
cognitive performance compared to higher glycemic index meals(14).
Hence, consumption of almonds with a meal can reduce the glycemic
impact of carbohydrate, thereby maintaining optimum blood glucose
concentrations for effective cognitive performance. However, monitoring
plasma glucose concentrations during the post-lunch phase when cognitive
function is waning might prove to be tricky as multiple measurements
within a short period can interfere with the decline in cognitive function
by promoting alertness. Hence, participants may need to be conditioned to
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the study process prior to testing to avoid the confounding effects of study
methods on cognition.

How would almond form influence vascular health and cognitive function?
o Individuals with vascular disease (VD) may have impaired endothelial
dependent dilation of blood vessels(15,16). Moreover, increasing evidence
suggests that vascular disease is associated with cognitive dysfunction(17).
These dysfunctions may be mediated by structural and functional changes
in the cerebral blood vessels. Epidemiological and clinical evidence
suggests that almond consumption may be an effective strategy for
lowering the incidence of VD and preventing cognitive decline(18).
Almonds contain a range of nutrients, the bioaccessibility of which are
dependent on the form of almonds. For example, nutrients in more
processed forms of almonds such as almond meal and almond butter are
more accessible for absorption than nutrients in whole almonds(19,20).
Hence, the increased bioavailability of nutrients from more processed
almond forms may reduce the risk of vascular disease and cognitive
impairments further. The role of almond form on vascular indices such as
endothelial function, vascular compliance and cognitive function has not
been investigated.
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How would the textural attributes of nuts affect acceptability and cognition?
o Although nuts have similar nutritional profiles, their textures are vastly
different, for example almonds are harder and more brittle than walnuts.
The textural properties of foods such as crispiness, crunchiness etc. can
influence the acceptability and enjoyment of food(21). The effects of
different textural profiles of nuts on their acceptability has not been
evaluated. Moreover, the relationship between mastication sounds and
cognition has not been explored. Foods such as nuts that are harder to
chew and those that elicit greater mastication sounds may increase
alertness and potentially affect cognitive function acutely in comparison to
foods that do not require considerable oral processing efforts.

What are the effects of lunch skipping and timing of lunch consumption on the
post-lunch dip in cognitive function?
o The post lunch dip analysis described in Chapter 5 did not account for the
timing of lunch consumption and the effects of lunch skipping on
cognitive function. Although a few studies have shown that the post-lunch
dip in cognitive function is not affected by the time at which lunch is
eaten(22,23) there is very limited evidence to derive firm conclusions. In
addition, there is inconsistent evidence regarding the effects of lunch
consumption versus no lunch on the post-lunch decline in cognitive
function(24). Therefore, there is a need to determine whether the post-lunch
dip induced by lunch intake in the early afternoon is different from that
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induced by lunch in the late afternoon and whether lunch skipping elicits a
post-lunch dip which is either more or less pronounced than that
experienced by lunch eaters.
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